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CHAPTER 1: Introduction 
Viruses are remarkably diverse in the ways they enter a host-cell and cause 
infection. Membrane coated viruses (i.e. enveloped) enter a host-cell by first 
binding to a receptor at the plasma membrane. Subsequently, an exposed viral 
fusion peptide interacts with the cellular components to induce membrane fusion 
events, which deliver the viral particle or genetic material into the host (1).  
 
Nonenveloped viruses represent a class of pathogens with entry mechanisms 
profoundly different from enveloped viruses (2). How nonenveloped viruses, 
containing a proteinacious capsid surface, cross a limiting host-cell membrane is 
poorly understood. This step in entry, referred to as membrane penetration, is 
absolutely required for the human pathogenesis caused by several viruses 
including reovirus, parvovirus, adenovirus and polyomavirus (2).  
 
The necessity of conformational changes or ‘activation’ of viral particles is a 
reoccuring theme among nonenveloped viruses (2). Host-factors present at 
specific cellular locations are responsible for inducing these conformational 
changes. Therefore, nonenveloped viruses need to first be internalized and 
trafficked to the appropriate region within the cell. For example, rotavirus and 
adenorvirus are endocytosed and targeted to endosomes (3, 4). For endosome 
membrane penetration these viruses are activated by proteases or the low pH 
environment. Structural changes within the capsid permit virus binding to the 
limiting membrane or release of viral components with lipolytic properties, which 
ultimately results in the disruption of membrane integrity.  
 
While general principles are known, in many cases the mechanism of membrane 
penetration is poorly understood. With improved mechanistic insight, this entry 
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step could be subjected to therapeutic intervention. The research presented in 
this thesis focuses on understanding membrane penetration by polyomaviruses 
(Pys).  
 
Human infection by polyomaviruses is nearly ubiquitous but generally remains 
subclinically latent (5). Several human polyomaviruses are known to cause 
disease, particularly individuals with weakened immune systems. For example, 
the very elderly, organ transplant recipients and AIDS patients are susceptible to 
diseases caused by BK polyomavirus (BKPyV), JC polyomavirus (JVPyV) or 
Merkel Cell polyomavirus (MCPyV). Affecting a spectrum of host-tissues, Py 
infections can lead to a diversity of severe pathologies. 
 
BKPyV lytic infection of kidney epithelial cells most prominently causes 
polyomavirus nephropathy (PVN) in patients receiving renal transplants. Patients 
with PVN have a 90% chance of allograft loss due to tissue necrosis (6). 
Approximately 5% of AIDS patients are afflicted by JCPyV lytic infection of 
oligodendrocites resulting in progressive multifocal leukoencephaloptahy (PML) 
(7). PML is a rapid neurodegenerative disease resulting in dementia, paralysis 
and death. Finally, MCPyV was discovered in Merkel Cell Carcinoma (MCC) and 
appears to play a causal role this rare and very lethal skin cancer (8). As with 
other human Pys, infection by MCPyV appears to be very common, therefore the 
factors controlling cellular transformation and the onset of disease warrant 
intense investigation.  
 
Currently, therapeutics aimed at stopping Py infections and consequences 
thereof are limited. When patients undergoing organ transplants encounter 
complications due to reactivated Py infection, the most common course of action 
is to reduce immunosupressive treatment. This treatment plan can lead to 
rejection of the transplant organ. 
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In a laboratory setting mouse polyomavirus (mPyV) and simian virus 40 (SV40) 
have been used as models to study events during cellular entry. mPyV and SV40 
serve as useful models of this family in part due to the ease of their production 
and their detailed structural characterization. As with other nonenveloped 
viruses, understanding the virion structure of Pys is essential for unraveling their 
mechanisms of entry. 
 
Key Structural Features of Polyomaviruses 
Three primary capsid proteins VP1, VP2 and VP3, comprise the viral particle of 
most Pys including mPyV and SV40 . MCPyV and perhaps a subset of other 
related Pys appear to lack VP3 (9). VP1 is the major capsid protein that forms 
the outer layer of the virus in an icosahedral geometry (10, 11). Each virus 
contains 360 copies of VP1 that are arranged as 72 pentamers (Figure 1-1A). 
The icosahedral geometry constructed from pentameric building blocks requires 
that not all VP1 pentamers share equivalent environments and chemical 
interactions. 60 pentamers are coordinated by six pentamers and 12 pentamers 
are surrounded by five pentamers, yielding multiple distinct pentamer interfaces 
(Figure 1-1B). For example, particularly strong contacts are made at the interface 
between pentavalent and hexavalent pentamers (11).  
 
Interactions between pentamers are maintained by the C-terminal sequences of 
VP1. This region is referred to as the C-terminal arm, because it extends away 
from each pentamer to invade and dock with the core of a neighboring pentamer 
(Figure 1-2A) (10-12). This interpentameric interaction drives the assembly of 
pentamers into full capsids, which are then stabilized by additional chemical 
forces. For example, highly conserved acidic residues on VP1 coordinate calcium 
ions to help fasten a VP1 arm into a target pentamer.  
 
Covalent disulfide linkages also contribute to overall capsid integrity. SV40 and 
mPyV contain seven and six cysteine residues respectively. SV40 has no 
intrapentameric disulfides but does have two interpentameric bonds (Figure 1-
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2A). These disulfides are produced by C9 and C104 of one pentamer interacting 
with the same residues of an adjacent pentamer (i.e. C9-C9 and C104-C104 
bonds) (10, 13). No other disulfides on infectious SV40 exist, however, C87 and 
C207 are important for folding and assembly and may form transient linkages. 
Crystallography data obtained for mPyV reveals only an intrapentameric disulfide 
between C19 and C114 (Figure1-2B). Similar to the effect of the aforementioned 
calcium ions, the positioning of this bond contributes to interpentameric 
stabilization by reducing the flexibility of the interlocking C-terminal arms. As the 
C114 residue of mPyV is analogous to C104 of SV40 and is instead used for an 
intrapentameric bond, it has been assumed that no interpentameric disulfides are 
present for mPyV.  However, structural data are absent for mPyV at the 
disordered N-terminus of VP1, which contains C11 and C15 (12).  
 
The minor capsid proteins VP2 and VP3 share identical sequences except for an 
N-terminal extension in VP2 (118 additional residues in the case of SV40). This 
VP2 N-terminus is myristolyated, hydrophobic and has alpha helical secondary 
structure. These proteins are buried underneath the VP1 pentamer surface with 
one VP2 or VP3 associating with a VP1 pentamer (14). Nearly every stage of the 
life cycle is influenced by the minor capsid proteins including particle assembly, 
genome packaging and entry. VP2 and VP3 also make contacts with the viral 
genome.  
 
The ~5 kb dsDNA genome of Py is packaged as a minichromosome with cell-
derived histones. This genetic material must reach the nucleus for infection and 
viral replication to occur. Nonstructural viral proteins capable of modulating 
intracellular signaling are produced by the host cell’s transcription and translation 
machinery. Large T-antigen (TAg) is the first of these viral proteins expressed 




While the complex structure of Py virions confers a resistance to the harsh 
extracellular milieu, many of the stabilizing forces described above are reversed 
during the course of host cell entry. This process is referred to as capsid 
uncoating or disassembly and is necessary for productive infection. As with other 
nonenveloped viruses, Pys rely on host factors to undergo uncoating at the 
precise time and cellular localization (2). 
 
Internalization and Sorting From Endosomes  
To cause infection, the dsDNA genome of Pys must be delivered from outside 
the host-cell to the cell nucleus. The study of how polyomaviruses enter host 
cells has historically focused primarily on two members of this family mPyV and 
SV40. However, the entry of human polyomaviruses such as BKPyV and JCPyV 
has also been interrogated (15-17). The entry pathway described below can be 
subdivided into distinct stages. 1) ganglioside receptor attachment at the plasma 
membrane 2) endocytosis and retrograde transport 3) ER arrival with subsequent 
conformational changes 4) ER membrane penetration into the cytosol and 5) 
nuclear import. 
 
The entry of Pys has been studied for over 25 years. A landmark study of SV40 
by Kartenbeck et al was the first to describe the unique endocytosis and 
trafficking of polyomaviruses (18). Although it was unclear at the time, their 
finding that SV40 particles become localized to the ER is now accepted to be the 
productive and infectious entry pathway of polyomaviruses. Brefeldin A (BFA) 
treatment disrupts COPI vesicle formation required for retrograde trafficking to 
the ER and potently blocks infection of mPyV, SV40, BKPyV and JCPyV(16, 17, 
19, 20). Secondly, perturbing ER homeostasis in a variety of ways decreases 
infection. While this mode of entry is also utilized by some bacterial toxins, 
trafficking to the ER by Pys is unique among viruses (21). 
 
To enter a cell, most polyomaviruses use direct contact between VP1 and 
glycolipid receptors called gangliosides on the plasma membrane (22-25). SV40 
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uses a ganglioside called GM1 and mPyV can use both GD1a and GT1b (24). 
While some glycoproteins serve to promote cell surface attachment of Pys or as 
nonproductive decoy receptors (26), gangliosides are well documented to be the 
entry receptors necessary for productive infection. This is most clearly evident 
from infection studies utilizing cell lines which lack complex gangliosides and are 
infected very poorly by Pys. When these cells are provided with purified 
gangliosides that can be incorporated into the cell surface, infectivity is 
dramatically restored (24, 27). This restored infectability is concomitant with 
increased ER localization, as gangliosides appear to drive not only internalization 
but subsequent vesicle sorting to the ER (28). As gangliosides span only one 
leaflet of a membrane bilayer, future studies must address the mechanism 
underlying how a ganglioside-bound virus transduces signals to direct these 
trafficking events. 
 
The endocytosis of SV40 and mPyV is mostly lipid raft/caveolae-dependent, 
clathrin-independent (27), however as with other steps in entry there are 
apparent differences among cell types (29). Notably, JCPyV utilizes a clathrin-
dependent entry pathway (30, 31), which is probably related to its apparent use 
of non-ganglioside entry receptors (32-34). During internalization of viral particles 
actin molecules undergo transient breakdown and recruitment at the site of 
endocytosis, where viruses pack tightly in plasma membrane derived tubules 
(35). Tyrosine kinase activity is also important for endocytosis of Pys (35). 
Contrary to previous accounts (36), endocytosed SV40 particles do not travel 
through a pH neutral organelle referred to as the caveosome. The presence of 
this organelle is an artifact of overexpressed caveolin-1 protein, the primary 
constituent of caveolae (37, 38). Instead, SV40 and other Pys are slowly 
transported in a microtubule-dependent retrograde manner through endosomes 
and lysosomes (28, 39). Pys are not observed in any Golgi compartments during 
entry, suggesting a Golgi-independent route or rapid viral transit through this 
organelle (27). Instead, the viral particles are sorted to the smooth ER 





Penetration of the Endoplasmic Reticulum Membrane for Arrival to the 
Cytosol 
The ER membrane is the limiting cellular membrane that must be breached for 
Pys to gain access to the cytosol and nucleus. Penetration of the ER membrane 
could allow direct access to the nucleus, however, several lines of evidence 
support a model whereby Pys primarily enter the cytosol prior to the nucleus 
(discussed below). Nonetheless, the ER contains several cellular factors which 
are co-opted by Pys to accomplish the task of membrane penetration. 
Intriguingly, these cellular factors are those which normally function in protein 
quality control (PQC) or aid in protein folding and biogenesis.  
 
The first step in membrane penetration involves the detachment of Pys from 
gangliosides allowing the virus to be deposited into the lumen of the ER. How 
this is accomplished is unclear. Upon release into the ER lumen, redox reactions 
are responsible for partial disassembly of the viral particle. In the case of SV40, a 
protein disulfide isomerase (PDI) family member called ERp57 is critical for this 
event (13). ERp57 is normally involved in assisting the folding and maturation of 
nascent glycoproteins in conjunction with the lectins calnexin (CNX) and 
calreticulin (CRT) (40). However, ERp57 acts independently of these factors 
when utilized by SV40. Using an unpaired Cys on VP1, ERp57 acts as an 
isomerase to disrupt the interpentameric disulfide bonds. This reaction effectively 
produces new intrapentameric disulfides and releases a subset of VP1 
pentamers from the viral particle. The canonical PDI is also important for 
infection but does not reduce or isomerize disulfide bonds on SV40 during entry. 
Instead, it may use chaperone activity to promote exit from the ER. The partial 
uncoating imparted by PDI-mediated reactions, and possibly other factors, 
results in the exposure of the minor coat proteins VP2 or VP3 (19, 41, 42). As 
these viral proteins contain hydrophobic moieties that can integrate into the ER 
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membrane, their exposure enables capsid binding to the ER membrane (43, 44). 
The process of membrane integration initiates nonenveloped virus membrane 
penetration.  
 
The capsid of mPyV has a different disulfide bond arrangement than SV40. 
Therefore, an outstanding question is whether mPyV also uses PDI family 
members for their oxidoreductase activities. In contrast to SV40, a PDI family 
member known as ERp29 is co-opted by mPyV to promote infection (43). ERp29 
has no documented redox activity but uses chaperone activity to maintain the 
proper oligomerization state and export of secreted ER proteins (45). In the 
context of mPyV, ERp29 uses its chaperone function to unfold the VP1 C-termini 
that stabilize the capsid structure (43). ERp29 requires its C-terminal substrate 
binding domain and the ability to dimerize to induce these conformational 
changes to mPyV (46, 47). Importantly, in vitro studies reveal that ERp29 
exposes the normally buried VP2 capsid protein, allowing the virus to bind to and 
perforate the ER membrane (48). The in vitro assay utilized for the unbiased 
identification of ERp29 required the use of mPyV that was pretreated with DTT 
for detection of full unfolding activity (43). Presumably this chemical reductant 
disrupts viral disulfide bonds that expose or loosen the C-terminal arm for 
complete unfolding by ERp29. Therefore, the use of an ER reductase or 
isomerase was hypothesized to be important in mPyV infection. In agreement 
with this, PDI downregulation blocks mPyV infection in HeLa cells but it was not 
tested whether PDI engage the virus directly (49). 
 
The research presented in Chapter 2 further explores the requirement of 
oxidoreductase activities during mPyV infection. Findings from this study suggest 
that the PDI family members ERp57, PDI and ERp72 are important for mPyV 
infection. Additionally, ERp57 and PDI are capable of disrupting disulfides on 
mPyV that are necessary for ERp29-mediated VP1 unfolding. Therefore, PDI 
family members work in a coordinated fashion to initiate membrane penetration.  
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After PDI-mediated priming events which lead to VP2 exposure (48), the 
abundant ER-resident Hsp70 chaperone, BiP, is also critical for Py exit from the 
ER (44, 50). Loss of function approaches depleting BiP levels from the ER are 
expected to induce massive cellular stress because BiP is required for protein 
translocation and folding. However a direct role for BiP in the ER exit of Pys is 
supported by the detection of physical BiP-SV40 interactions (50). BiP is 
currently the only ER resident protein known to form a stable complex with Pys in 
cells. Disrupting the function of BiP cochaperones, which regulate BiP binding 
activity, also decreases virus arrival to the cytosol without preventing exposure of 
VP2 (50). BiP is hypothesized to minimize nonproductive interactions by 
shielding hydrophobic regions of the virus that are not buried in the ER 
membrane during penetration. 
 
Once hydrophobic Pys have engaged the ER membrane they are recognized by 
a PQC system known as ER-associated degradation (ERAD) (51). The highly 
organized process of ERAD begins with the recognition of misfolded or 
unassembled protein subunits by lumenal chaperones or membrane proteins. 
The aberrant substrate protein is targeted to specialized machinery on the ER 
membrane for retrotranslocation into the cytosol for subsequent ubiquitination 
and proteasomal degradation. Treatment with proteasome inhibitors strongly 
inhibits successful Py entry (13, 15, 16, 20), originally suggesting the importance 
of the ERAD pathway in membrane penetration. Proteasome inhibition stalls 
ERAD and leads to substrate accumulation at all stages of the pathway. Under 
these conditions ERAD factors, which would otherwise engage Pys, are 
saturated with misfolded proteins that fail to be degraded normally.  
 
Importantly, siRNA knockdown screens have identified a subset of ERAD 
membrane proteins that are critical for Py infection, specifically during the ER-to-
cytosol transport stage of entry. It is unclear whether Pys breach the ER 
membrane directly or utilize a large protein channel. Due to their localization, a 
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thorough characterization of the ER membrane proteins used by Pys is central to 
understanding the precise mechanism of membrane penetration.  
 
The presence of the ERAD membrane proteins Derlin-1, Derlin-2 and Sel1L is 
important for entry of Pys. siRNA knockdown of Derlin-1 and Sel1L decreased 
SV40 infection by approximately 50% (13). Knockdown of Sel1L blocks infection 
of JCPyV similarly (17). Derlin-1-YFP and Derlin-2-YFP overexpression 
negatively affects some ERAD pathways by perturbing the structure of 
endogenous Derlins to which they oligomerize with (52). Overexpression of these 
variants also perturbs BKPyV and mPyV infection respectively (16, 53). The 
exact role these proteins serve during membrane penetration remains to be 
clarified. During ERAD, Derlin proteins recruit cytosolic p97, an ATPase which 
provides a driving force in the dislocation of substrates into the cytosol (54, 55). 
Sel1L is a scaffolding protein that allows targeting of misfolded glycoproteins to 
its primary binding partner, the E3 ubiquitin ligase, Hrd1 (56, 57). The finding that 
p97 and Hrd1 are not important for SV40 infection further muddles the exact role 
for Derlins and Sel1L (44). Without supporting evidence highlighting a particular 
action these factors carry out, the effects produced by their loss of function could 
be indirect, as with proteasome inhibition. 
 
Recently, some mechanistic insight has been obtained for how ERAD 
components facilitate membrane penetration. A study by Gieger et al identified 
important details surrounding the initial recognition of membrane bound SV40 by 
ERAD machinery (44). Analyses in vitro confirmed that conformational changes 
occur to SV40 that permit membrane binding, with the exposure of VP2 being of 
primary importance. The N-terminus of VP2 having alpha helical and 
hydrophobic characteristics becomes integrated with membranes. Yet a 
conserved charged Glu (E17) residue is also present near the N-terminus of 
VP2. Mutation of this residue abolishes the ability of SV40 to cause infection 
entirely. E17 of VP2 is hypothesized to be the signal recognized by a membrane 
component called BAP31 to initiate retrotranslocation. BAP31, which is 
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implicated in numerous processes including ERAD, contains two charged 
residues within a transmembrane domain that are complimentary to E17 in VP2. 
Therefore, BAP31 may weakly interact with membrane embedded virus 
electrostatically. Interestingly, virions containing VP2 induced a drastic 
reorganization of BAP31 into discrete foci containing virus. The functional 
significance of these structures is not understood and warrants further 
investigation.  
 
A study by Goodwin et al also identified ER membrane proteins critical for the ER 
membrane penetration of Pys: DnaJB14 (B14), DnaJB12 (B12) and DnaJC18 
(C18) (50). These three factors share 40-50% sequence identity, span the ER 
membrane once and contain a highly conserved J domain in the cytosol. J 
domain containing proteins, termed J proteins, typically function as 
cochaperones to stimulate the ATPase regulated substrate binding of Hsc70s 
(58). Whether a functional J domain of B14, B12 and C18 is required to facilitate 
Py infection is not known. B14 and B12 are both implicated in the ERAD of the 
membrane substrates (59-61). C18 has not been studied in the context of ERAD 
and may be less important than B14 and B12 for Py infection.  
 
The research presented in Chapter 3 focuses on characterizing the role of B14 
and B12 in SV40 membrane penetration. The findings reveal that B14 and B12 
are in fact unified with BAP31 in promoting SV40 exit from the ER. Importantly, 
these J proteins serve to recruit Hsc70 and another cytosolic chaperone called 
small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) to 
the ER membrane. Cell based assays suggest that chaperone recruitment and 
their interactions with SV40 are important for the completion of membrane 
penetration. 
 
Membrane penetration is completed upon cytosol arrival. Contributing to the 
enigma of membrane penetration are results from a characterization of cytosol 
localized viral particles obtained during entry. Remarkably, some SV40 particles 
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can be observed directly and biochemically to reach the cytosol as large, intact 
and containing all capsid components (20). Other particles within the cytosol are 
smaller and have a profoundly distorted shape. Thus, Pys are hypothesized to 
penetrate the ER membrane intact before they undergo more severe 
disassembly due to the cytosol’s reducing potential and low calcium 
concentration. This scenario is in line with SV40’s genome becoming exposed 
only upon cytosol arrival (42). Hsc70 chaperones are also known to disassemble 
mPyV in vitro and may assist in this process during entry (62). 
 
Microinjection and biochemical studies support a model whereby SV40 utilizes 
the cytosolic arrival and classical nuclear import mechanisms for transport of its 
genome into the nucleus. The microinjection of antibodies against VP1 or VP3 
into the cytosol blocks expression of virally encoded TAg in the nucleus (i.e. 
nuclear import and infection) (63). Cells with SV40 particles microinjected into the 
cytosol begin to express the viral protein large T-antigen (TAg) successfully 
within several hours, a widely used experimental readout for infection. When the 
‘naked’ viral genome is microinjected into cells, TAg expression is inefficient, 
indicating capsid proteins contribute to the nuclear import of the viral genome to 
which they associate with. Moreover, importin family proteins can be detected in 
complex with SV40 during entry (64). 
 
Pronounced disassembly in the cytosol is predicted to be important for several 
reasons. The subviral particle produced in the cytosol would present exposed 
NLS of capsid proteins and not exceed the size limit of the nuclear pore complex. 
Moreover, a disassembled particle would permit access of cellular machinery to 
the viral genome during transcription. In vitro experiments notwithstanding, host 
proteins that aid in this process in cells are unknown. 
 
Why do Pys take such an elaborate path into the host-cell? Clearly, the ER 
provides an ideal environment for oxidoreductase and chaperone-mediated 
conformational changes. Also trafficking to the ER and penetrating ‘late’ allows 
 13	  
for the particles to arrive in the cytosol near the center of the cell, close to the 
nucleus (65). In some instances, this allows the capsid to avoid the crowded 
cytoplasmic environment as much as possible. Some portions of the ER, 
however, are observed near the plasma membrane. It is unclear whether Pys 
traffic to specific regions or subdomains of the smooth ER for efficient entry. As 
such a low percentage of virions reach the cytosol, ER membrane penetration 
appears to be a rate-limiting step of entry. A mechanistic understanding of this 
transport step could reveal therapeutic targets for preventing diseases caused by 
human Py infection.  
 
The extensive use of protein quality control factors during membrane penetration 
by Pys deviates from the mechanisms used by other nonenveloped viruses. This 
could be in large part due to the unique delivery of Pys to the ER, whereas 
parvovirus and adenovirus penetrate the endosomal membrane (2). 
Conformational changes to parvovirus and adenovirus are still critical for pore 
formation and membrane disruption, however activation events are instead 
triggered by low pH or proteases (2, 3, 66). In contrast to endosomes, permanent 
lysis of the ER would cause cell death. Because of this, ER membrane 
penetration may be a more organized process with additional mechanistic 
complexity. 
 
This thesis divides the ER-to-cytosol transport step into two stages. Details 
surrounding the initiation or priming events allowing Pys to bind the ER 
membrane is presented in Chapter 2. Data presented in Chapter 3 demonstrate 
that membrane penetration is completed by recruitment of cytosolic chaperones. 
Finally, conclusions drawn from this research and future directions are presented 


















Figure 1-1. VP1 is the major capsid protein of Pys and has complex 
arrangement.  
 
(A) Depiction of VP1 proteins, which assemble from 360 copies into 72 
pentamers per virus. One VP2 or VP3 minor capsid protein is buried beneath 
each pentamer (not shown).  
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(B) VP1 pentamers have multiple distinct interfaces. 60 pentamers are 
surrounded by six other pentamers and are referred to as hexavalent (blue). The 






Figure 1-2. Known interpentameric interactions of model Pys, SV40 and 
mPyV.  
 
(A) SV40 contains two types of interpentameric disulfide bonds with cysteine 
residues in position 9 and 104 interacting with the same residues of a 
neighboring pentamer i.e. C9-C9 and C104-104 (orange arrows). Due to the 
distinct pentamer interfaces these disulfide bonds are not always present, for 
example C104 can also exist in a reduced state. Every C-terminus of VP1 (gray 
wavy line) extends away from one pentamer, enters a neighboring pentamer and 
makes hydrophobic contacts.  
(B) mPyV lacks known interpentamer disulfides. C114, which is analogous to 
C104 of SV40, forms an intrapentamer linkage with C19 (orange arrows). This 








Figure 1-3. Cellular entry pathway of Pys. 
 
Pys (red) bind to ganglioside receptors (green) on the plasma membrane to 
induce endocytosis (far left). Viral particles traffic through endosomes and 
lysosomes before being sorted to the endoplasmic reticulum (ER). From the ER, 
conformational changes imparted to the virus permits membrane penetration into 
the cytosol, where particles arrive large and intact. The reducing conditions, low 
calcium concentration and presence of chaperones within the cytosol cause 
disassembly into subviral particles which enter the nucleus using the nuclear 
pore complex (blue). Viral gene expression stimulates replication and 
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CHAPTER 2: PDI Family Members Act Distinctly and Coordinately to 
Facilitate Murine Polyomavirus Infection 
 
INTRODUCTION 
Penetration of the host-membrane represents a decisive step in virus infection. 
For enveloped viruses that are surrounded by a lipid bilayer this process requires 
fusion of viral and host membranes, resulting in the delivery of the inner viral 
particle across the limiting membrane (1, 2). A mechanistic understanding of 
membrane penetration by nonenveloped viruses is less clear but appears to be 
fundamentally different. Common principles governing this important process 
have emerged from several studies within the past two decades. 
 
One central principle involves the ability of the nonenveloped virus to undergo 
productive conformational changes. These structural changes to the viral capsid 
may generate a hydrophobic viral particle or release an internal virus peptide 
harboring intrinsic lytic activity (often called a lytic peptide) buried inside the 
native virus (3). Disruption of the limiting membrane by this peptide enables virus 
transport across the membrane. In both instances, the critical trigger for virus 
transport is the conformational change the viral particle experiences. These 
structural alterations often occur as a result of concerted or sequential actions 
among numerous cellular factors acting upon the virus. How the distinct functions 
of each contributing cellular factor are coordinated to produce the final, 
penetration-competent capsid is unclear but is likely to be unique to the native 
structure of the capsid. For efficiency during entry the majority of conformational 
changes should be imparted precisely at the site of membrane penetration. 
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For successful infection of a host-cell, the nonenveloped murine polyomavirus 
(mPyV) binds to the gangliosides GD1a or GT1b and is transported in a 
retrograde manner to the endoplasmic reticulum (ER) (4-8), where the virus 
penetrates the ER membrane to access the cytosol. mPyV is ultimately 
transferred into the nucleus, where transcription and replication of the viral 
genome leads to propagation of new viral particles. As with other nonenveloped 
viruses, recent studies imply that the membrane penetration of Pys is a complex 
event requiring conformational changes within the capsid structure (9-11). 
 
The mPyV capsid is comprised of 360 copies of the major coat protein VP1, 
which are arranged in a icosahedral geometry of 72 pentamers enclosing a 
dsDNA genome (12). Twelve of the pentamers are surrounded by five other 
pentamers (i.e. five-coordinated), while the remaining 60 pentamers are 
surrounded by six other pentamers (i.e. six-coordinated). Each pentamer 
associates with a single copy the minor coat protein VP2 or VP3, which are 
buried from the surface of a native virion (13).  
 
Three reversible forces stabilize the architecture of the viral capsid. First, the C-
terminus of VP1 (C-terminal arm) invades a neighboring pentamer (12, 14, 15). 
These hydrophobic surface contacts effectively stabilize interpentamer 
interactions. Second, intrapentamer disulfide bonds between cysteine 19 of one 
monomer and cysteine 114 of another monomer further stabilize the VP1 capsid 
by ‘clamping down’ on the C-terminal arms (14). Interestingly, the analogous 
residues in the related simian virus 40 (SV40) form interpentameric disulfide 
bonds(14). While the X-ray structure of mPyV indicates that C273 and C282 exist 
unbonded with free thiols, this structure does not provide information on the 
remaining C11 and C15 residues located at the disordered N-terminus of VP1 
(12). C11 and C15 may be fully reduced, form inter- or intrapentameric disulfide 
bonds or exist as a mixed population dependent on their positioning in relation to 
neighboring pentamers. Finally, calcium ions are coordinated by acidic residues 
in VP1 that contribute further to stabilize the capsid (16). Thus, local unfolding of 
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the VP1 C-terminal arm, disulfide bond disruption, and removal of calcium ions 
are reactions that destabilize Pys, initiating the uncoating process that prepares 
the virions for ER membrane penetration.  
 
The host activities responsible for these structural disruptions, however, have not 
been fully defined. In the case of SV40, the ER-resident PDI family member 
ERp57 has been reported to isomerize interpentameric disulfide bonds into 
intrapentameric linkages resulting in the release of a subset of pentamers (17). 
This modification to VP1 by ERp57 is critical for infection and may contribute to 
the exposure of internal VP2 or VP3 proteins. For mPyV, an ER resident PDI-like 
protein called ERp29 was identified to be necessary for infection (11). ERp29 
functions to produce conformational changes to VP1 that unfold the C-terminal 
arms of VP1 and expose the hydrophobic VP2 without global disassembly of the 
capsid (18). Due to the hydrophobicity of VP2, this remodeling event permits 
membrane binding by mPyV (11). Interestingly, siRNA downregulation of ERp29 
does not appear to inhibit SV40 infection (17). Collectively, these results indicate 
that PDI protein requirements and virus priming reactions (i.e. viral 
conformational changes) may vary among different species of polyomaviruses.  
 
In this study, using a combination of cell infection studies and in vitro 
biochemistry, we identify a network of ER-resident protein disulfide isomerase 
(PDI) proteins called ERp57, PDI, and ERp72 that facilitate infection and act on 
mPyV’s disulfide bonds in vitro. Additionally, our data reveal an important role of 









MATERIALS AND METHODS 
 
Reagents 
Crude and purified mPyV, NIH 3T3 cells and “M1” VP1 antibody were generously 
provided by T. Benjamin (Harvard Medical School, Boston, MA). Polyclonal “I-58” 
VP1 antibody was provided by R. Garcea (University of Colorado, Boulder, 
Colorado), the polyclonal antibody against ERp29 was a gift from S. Mkrtchian 
(Karolinska Institutet, Stockholm, Sweden), the polyclonal antibody against 
ERp57 was a gift from S. High (University of Manchester, Manchester, England), 
and the polyclonal antibody against Derlin-1 was a gift from T. Rapoport (Harvard 
Medical School, Boston, MA). The monoclonal antibody against BiP was 
purchased from BD Biosciences (San Jose, CA). The polyclonal antibody against 
PDI was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The 
polyclonal antibody against ERp72 was purchased from Assay Designs (Ann 
Arbor, MI). Dulbecco’s modified Eagle’s medium (DMEM), Optimem, 
Lipofectamine 2000, and 0.05% trypsin-EDTA were purchased from Invitrogen 
(Carlsbad, CA). Fetalclone III (FC) was purchased from HyClone (Logan, UT). 
Complete Mini EDTA-free protease inhibitor cocktail tablets were purchased from 
Roche (Indianapolis, IN). The cross-linking reagent dithiobis 
succinimidylpropionate (DSP) was purchased from Pierce Biotechnology 
(Rockford, IL). Reduced and oxidized glutathione, Proteinase K, trypsin, DTT, 
NEM and anti-FLAG M2-agarose were purchased from Sigma (St. Louis, MO). 
Calmodulin was purchased from Calbiochem. Micro Bio-Spin P-30 Tris 
Chromatography Columns were purchased from Bio Rad.  
 
siRNA Knockdown 
Stealth RNAi negative control duplexes (low or medium GC % duplex) were 
purchased from Invitrogen. Duplex siRNAs corresponding to a segment of mouse 
PDI (siRNA #1 5’-GCA ACA ACU UUG AGG GUG AUU-3’; 5’-UCA CCC UCA 
AAG UUG UUG CUU-3’, siRNA #2 5’-GCA ACA ACU UUG AGG GUG AUU-3’; 
5’-UCA CCC UCA AAG UUG UUG CUU-3’), mouse ERp57 (siRNA #1 5’-CCA 
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GCA ACU UGA GAG AUA ATT-3’; 5’-UUA UCU CUC AAG UUG CUG GCT-3’, 
siRNA #2 5’-GCC AGC AAC UUG AGA GAU AUU-3’; 5’-UAU CUC UCA AGU 
UGC UGG CUU-3’), and mouse ERp72 (siRNA #1 5’-GCA GUU UGC UCC AGA 
AUA UTT-3’; 5’-AUA UUC UGG AGC AAA CUG CTT-3’, siRNA #2 5’-UGA CAA 
AGA UAC AGU GCU AUU-3’; 5’-UAG CAC UGU AUC UUU GUC AUU-3’)  were 
synthesized by Invitrogen. 100 nM (ERp57 siRNA #2, ERp72 siRNA #2) or 200 
nM duplexed siRNAs (ERp57 siRNA #1, ERp72 siRNA #1, PDI siRNA #1 and 
#2) were transfected into 15-30% confluent NIH 3T3 cells using Lipofectamine 
2000 according to the manufacturer’s protocol. Negative control duplexes were 
transfected similarly at 100 nM or 200 nM concentrations. Protein expression 
was assessed by SDS-PAGE and immunoblot analysis at 72 h post-transfection. 
Infection assays were initiated 72 h post-transfection. 
 
XBP1 Splicing Assay 
Detection of XBP1 splicing was performed as described previously in reference 
(19). The forward and reverse primers used were 5’ GAA CCA GGA GTT AAG 
AAC ACG 3’ and 5’ AGG CAA CAG TGT CAG AGT CC 3’ respectively. 
 
Infection Assays 
Cells treated with the indicated siRNA were plated on glass coverslips 48 h post-
transfection at a density of 3 × 104 cells/well in a 6-well plate. At 72 h post-
transfection, crude mPyV (100 PFU/cell) was added to cells in fresh DMEM plus 
10% FC. The infected cells were incubated at 37°C for 24 h, washed with PBS, 
provided with fresh DMEM plus 10% FC, and allowed to incubate for an 
additional 24 h. Cells were then fixed and stained with a rat monoclonal antibody 
against mPyV large T antigen and a rhodamine-conjugated donkey anti-rat IgG 
(Jackson ImmunoResearch, West Grove, PA). In each experiment, at least 500 
cells per condition were scored for the absence or presence of nuclear large T 
antigen expression using standard immunofluorescence microscopy as before 
(20). A Nikon epifluorescence microscope (Model Eclipse TS100, Melville, NY) 
equipped with a TexasRed emission filter and a 40× objective was used. 
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Production of Recombinant PDI, ERp57, and ERp72 
PDI proteins were expressed and purified as before(21). Full length mouse PDI, 
human ERp57, and mouse ERp72 containing N-terminal His6 tag were expressed 
from pQE30 (Qiagen) constructs in Escherichia coli strain BL21-pro (Clontech) 
for 2-4 h at 37°C upon induction with isopropyl thio-β-galactoside (1 mM, 
Invitrogen). Cells were lysed by incubation in buffer containing 1% Triton X-100, 
300 mM KOAc, 250 mM sucrose, 2mM Mg(OAc)2 50 mM HEPES (pH 7.5) and 
protease inhibitors, followed by sonication. Lysates were centrifuged, and the 
resulting supernatant fractions were applied to a nickel nitrilotriacetic acid-
agarose column (Qiagen) in the presence of imidazole (20 mM, Sigma). The His-
tagged proteins were eluted from the column with imidazole (100, 300 or 500 
mM). Eluates containing purified proteins were dialyzed extensively overnight in 
PBS, frozen in liquid nitrogen and stored at -80°C. 
 
mPyV Reduction and Isomerization Assays 
Reaction mixtures were incubated for 1 h at 37°C containing the indicated 
components. Each reaction mixture was subjected to nonreducing SDS-PAGE 
followed by immunoblotting with an antibody against VP1. In Figure 2B-D, 
untreated purified Py (100 ng) was incubated in the presence or absence of 
ERp57 (8 mM), ERp72 (6 mM), or PDI (5 mM). ERp57 (heat-treated) denotes 
protein heated for 1 h at 95°C prior to incubation with Py. NEM treated ERp57, 
ERp72 and PDI denotes protein reacted with NEM (10 mM) for 2 h at 37°C 
followed by overnight dialysis against PBS to remove excess NEM. In Figure 2-
3C-D reaction mixtures were treated as in Figure 2-2B-D except virus used was 
either mock treated or NEM treated as indicated. Where indicated, DTT (5 mM) 
was added to the reaction mixtures. 
 
Acid Pre-treatment of mPyV 
WT Py was pre-treated with acidic conditions (pH 5) or neutral conditions (pH 7) 
as before (6). 
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Alkylation of mPyV 
Crude or purified Py was alkylated with NEM (10 mM) for 2 hrs at 37°C or mock-
treated. Excess NEM was removed efficiently with subsequent buffer exchange 
using a spin column (Bio Rad) according to the manufacturer’s protocol. 
 
Trypsin Digestion Assays 
An ER lumenal extract was produced from dog pancreatic microsomes by three 
freeze-thaw cycles followed by centrifugation of the microsomes at 50,000 x g for 
30 min to remove the membrane material. Contents in the supernatant represent 
soluble proteins in the ER lumen, referred to as an ER lumenal extract. Trypsin 
digestion assays were performed similarly to those described previously(11).  For 
experiments using crude virus, virus was pretreated with DTT (3 mM) and EGTA 
(10 mM) for 20 min at 37°C followed by the addition of the ER lumenal extract or 
BSA (1 mg/ml) and continued incubation for 1 h at 37°C. Reaction mixtures were 
then treated with or without trypsin (0.25 mg/ml) for 30 min at 4°C. The reaction 
was stopped by the addition of TLCK (1 mM) for 10 min at 4°C. Samples were 
analyzed by reducing SDS-PAGE followed by immunoblotting with a VP1 
antibody. 
 
For experiments using purified mPyV, an ER lumenal extract enriched for ERp29 
was used as described in (11, 18, 22). This extract was pretreated with DTT (1 
mM) for 1 h at 37°C followed by 3-6 hr dialysis against PBS to remove excess 
DTT. Calmodulin was also dialyzed against PBS to remove trace amounts of 
protease inhibitors. Purified mPyV (50 ng) was first incubated with the indicated 
protein (10 mM) and EGTA (10 mM) for 1 h at 37°C. An ER lumenal extract (1 
mg/ml) was then added to the reaction mixtures and incubated for 30 min at 
37°C. Trypsin (0.25 mg/ml) was added next and the incubation proceeded for 30 
min at 4°C. The reaction was stopped by the addition of TLCK (1 mM) for 10 min 
at 4°C. Samples were analyzed by reducing SDS-PAGE followed by 
immunoblotting with a VP1 antibody.  
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Construction of N-terminally FLAG-tagged rat ERp29  
The cDNA of ERp29 was amplified by PCR using a 5’-primer containing the 
FLAG-tag sequence with pcDNA3.1(+)-rat ERp29 as a template (18). The 
fragment was inserted into modified pcDNA3.1 (Invitrogen) that contains the 
ERp29 signal sequence. 
 
Chemical Cross-linking and Co-immunoprecipitation Analyses 
NIH 3T3 cells were grown to 80-90% confluency on a 10 cm dish before being 
transfected with constructs expressing rat ERp29 or N-terminally FLAG-tagged 
rat ERp29 using Lipofectamine 2000 according to the manufacturer’s protocol. At 
48 h post-transfection, cells were harvested, pelleted and washed twice with 
PBS. Where indicated cells were treated with the DSP crosslinker or mock 
treated. DSP dissolved in DMSO (25 mM) was diluted to a concentration of 1 mM 
into 1.5 ml of PBS, which was used to resuspend cells followed by incubation for 
1 h at 4°C. Cells were pelleted and the DSP removed. After washing with PBS, 
cells were lysed for 30 min at 4°C in a buffer containing 1% Triton X-100 for DSP 
treated cells or 1% deoxyBigChap for mock treated cells. Cells were centrifuged 
at 16,000 x g for 15 min and 10% of the supernatant was taken as input. A 30 ml 
slurry of an anti-FLAG M2 agarose was equilibrated and added to the remaining 
supernatant and incubated overnight at 4°C. Agarose was pelleted and the 
supernatant removed before extensive washing. Samples were subjected to 
SDS-PAGE followed by immunoblotting with the appropriate antibody.  
 
Mutagenesis of Py and Analyses of WT and Mutant Viruses  
The WT mPyV genome (RA strain) cloned into a PBS vector was generously 
provided by T. Benjamin (Harvard Medical School, Boston, MA) and used as a 
template for PCR-based site directed mutagenesis with a QuickChange II site-
directed mutagenesis kit from Stratagene (La Jolla, CA). Desired mutations were 
confirmed by sequencing. The viral genomes were removed from the PBS 
construct by restriction digest and religated in a dilute reaction. Purified WT or 
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mutant genomes were transfected into 80-90% confluent NIH 3T3 cells using 
Lipofectamine 2000 according to manufacturer’s protocol. After 24 h, cells were 
washed and provided with fresh media containing penicillin-streptomycin 
(Invitrogen). Media containing viral particles was collected 5-7 days post-
transfection and used for subsequent infection and in vitro experiments. Media 
containing viral particles was subjected to reducing or nonreducing SDS-PAGE 
and immunoblotting with an antibody against VP1. Infection assays were 
performed essentially as described above, treating cells with equal amounts of 
crude WT or mutant virus as determined by VP1 signal in immunoblots. 
 
Proteolytic Analyses of WT, Alkylated and mPyV mutants 
Crude WT, mutant, alkylated or mock-treated mPyV was incubated for 30 min at 
4°C with various concentrations of proteinase K as indicated. Samples were 
subjected to reducing SDS-PAGE followed by immunoblotting with an antibody 
against VP1. 
 
Native Agarose Electrophoresis of WT and Mutant mPyV 
Crude WT or mutant viruses were mixed with sample-loading buffer without 
reducing agent or SDS and loaded onto a 0.4% agarose gel. Electrophoresis in 
50 mM Tris-acetate (pH 8.1) was carried out at 4°C for at least 3.5 h, replacing 













Downregulation of ERp57, ERp72, and PDI reduces mPyV infection 
We sought to investigate the role of PDI proteins in mPyV infection as they may 
assist in capsid remodeling events with their oxidoreductase activities. Due to 
their high levels of expression, we chose to assess the importance of three PDI 
family members called ERp57, ERp72 and PDI in the entry of mPyV. Each of 
these PDI family members were individually downregulated in the murine 
fibroblast NIH 3T3 cells using siRNAs against ERp57, PDI, and ERp72. 
Immunoblot analysis was first performed using transfected cell lysates at the time 
of virus addition. In cells treated with the ERp57-specific siRNA #1, the ERp57 
level decreased with only a subtle increase in expression of PDI and ERp72. 
(Figure 2-1A, first, second, third, and fourth panel, compare lane 2 to 1). 
Downregulation of ERp57 did not  cause detectable upregulation of two 
prominent unfolded protein response (UPR) markers BiP and Derlin-1 (23) 
(Figure 2-1A, 5th and 6th panels, compare lane 2 to 1), indicating that loss of 
ERp57 did not cause profound ER stress. ERp72 (Figure 2-1A, second panel, 
lane 3) and PDI (Figure 2-1A, third panel, lane 4) were also downregulated with 
similar efficiency and specificity. Again, in these cases, BiP and Derlin-1 
expression was also not increased. (Figure 2-1A, 5th and 6th panels, compare 
lanes 3 and 4 to 1).  
 
To further assess whether knockdown of the PDI proteins (using siRNA #1) 
causes ER stress leading to UPR induction, we monitored the splicing of the 
XBP1 transcription factor mRNA (19)(Figure 2-1B). In contrast to incubating cells 
with the known ER stress inducers DTT and tunicamycin (Figure 2-1B, compare 
lanes 2 and 3 to 1) siRNA-mediated knockdown of ERp57, ERp72 or PDI did not 
result in splicing of XBP1 (Figure 2-1B compare lanes 4-6 to 2-3). Collectively 
this data indicates that the three PDI family proteins can be effectively down-
regulated without inducing detectable levels of ER stress. 
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Using the above knockdown conditions, mPyV infection was measured with 
immunofluorescence microscopy by quantifying the percentage of cells positive 
for expression of the virus-encoded large T antigen. When compared to 
scrambled siRNA treated cells, infection was reduced by approximately 40% 
when each PDI protein was individually knocked down with siRNA #1 (Figure 2-
1C, siRNA#1). A similar block in infection was observed when a second distinct 
set of siRNAs was used to downregulate ERp57, ERp72 and PDI (Figure 2-1C, 
siRNA#2). When simultaneous downregulation of all three PDI family proteins 
was attempted, cells appeared unhealthy in their overall morphology and number 
compared to the scrambled transfected control. When two PDI family members 
were simultaneously downregulated in all combinations using siRNA #1 (Figure 
2-1D, top three panels), ER stress remained undetectable (Figure 2-1D, 4th, 5th, 
and 6th panels; Figure 2-1E). Under these double knockdown conditions, 
infection was reduced by at least 60% in all combinations (Figure 2-1F). The 
average infection decrease is significantly different when comparing single and 
double knockdown experiments (Figure 2-1G). We conclude that efficient mPyV 
infection requires multiple PDI family members including PDI, ERp57 and ERp72. 
 
ERp57, PDI, and ERp72 disrupt disulfide bonds on mPyV in vitro 
PDI was previously implicated in the infection of HeLa cells by mPyV but it is not 
known if PDI or PDI-like proteins act directly on the virus (9). Several PDI family 
members are well documented to oxidize, reduce or isomerize disulfide bonds 
(24). Therefore, we tested our hypothesis that some PDI family members could 
act directly on mPyV by disrupting viral disulfide linkages. Mammalian PDI, 
ERp57, and ERp72 were expressed in bacteria with N-terminal His tags and 
purified to homogeneity (Figure 2-2A, lanes 1-3). We first examined the activity of 
ERp57. Purified mPyV was incubated in the presence or absence of ERp57 and 
subjected to nonreducing SDS-PAGE and immunoblotting with an antibody 
against VP1. In reactions lacking ERp57, immunoblotting for VP1 did not detect 
any bands (Figure 2-2B, lane 1). This is indicative of the presence of only 
unmodified virus, which fully intact is too large to migrate into the gel. By 
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contrast, band patterns corresponding approximately to the sizes of VP1 
monomer (42 kDa), trimer (126 kDa), pentamer (210 kDa), and higher oligomers 
were observed when mPyV was incubated with ERp57 (Figure 2-2B, compare 
lane 2 to 1). No pattern was detected when ERp57 was incubated in the absence 
of virus (Figure 2-2B, lane 5), demonstrating that the signals observed in the 
presence of virus are virus-derived products.  
 
When ERp57 was denatured with heat prior to incubation with the virus, the 
various Py-derived species were not seen (Figure 2-2B, lane 3) indicating the 
conformation of ERp57 is important for this activity. Additionally, the activity of 
ERp57 was lost upon pretreatment with the alkylating reagent N-ethylmaleimide 
(NEM) to modify free cysteine residues (Figure 2-2B, lane 4). We conclude that 
the catalytic cysteine residues of ERp57 can directly disrupt at least some 
disulfide bonds on mPyV to generate the virus-derived species.  
 
During entry, mPyV traffics through the low pH endolysosome system before 
reaching the ER (6). As these conditions contribute subtle conformational 
changes we asked whether pretreatment of mPyV with low pH (i.e. pH 5) could 
affect the ability of ERp57 to generate the VP1-derived products. However, no 
significant differences in the amount or size of reaction products were detected 
(Figure 2-2C, compare lane 2 to 1).  
 
The same pattern of VP1-derived products were also generated when PDI but 
not NEM-treated PDI (Figure 2-2D, compare lane 1 to 2) was incubated with (but 
not without) mPyV. PDI also acted on low pH-treated virus with similar efficiency 
as control virus (Figure 2-2E, compare lane 1 to 2). Finally, the VP1-derived 
products were produced when ERp72 but not NEM-treated ERp72 (Figure 2-2F, 
compare lane 1 to 2) was incubated with (but not without) mPyV. Again, 
pretreating mPyV with low pH did not significantly influence the ability of ERp72 
to act on the virus (Figure 2-2G, compare lane 1 to 2). Therefore PDI and ERp72 
also use their cysteines to produce the virus-derived products. The ER redox 
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conditions were mimicked in reactions containing a 1:1 molar concentration of 
oxidized glutathione (GSSG) and reduced glutathione (GSH) (17). Under these 
conditions, the VP1-derived products were also generated. We conclude that 
even under the relatively oxidizing ER conditions, PDI proteins can break 
disulfide bonds on the mPyV capsid.	  
 
ERp57 and PDI function coordinately with ERp29 to induce conformational 
changes to mPyV in vitro 
Previously, we developed an in vitro assay utilizing limited proteolysis to monitor 
conformational changes imparted to mPyV by an activity within an ER lumenal 
extract (11). Using this assay, a PDI-like protein called ERp29 was identified as a 
chaperone responsible for unfolding (exposing to protease) the VP1 C-terminal 
arms that stabilize the viral capsid. Importantly, this unfolding reaction was 
significantly more efficient upon addition of a reducing agent, presumably to 
disrupt viral disulfide bonds. To study the potential influence of ERp57, ERp72 
and PDI in ERp29-mediated C-termini unfolding, we modified this assay by using 
an ER lumenal extract enriched with ERp29 and dilute in other PDI proteins. 
 
When mPyV was incubated with bovine serum albumin (BSA) in the presence of 
DTT and EGTA (to remove the virus-bound calcium) followed by trypsin addition, 
a VP1-derived fragment, labeled as VP1a, was generated (Figure 2-3A, compare 
lane 2 to 1). However, when virus was instead incubated with ER lumenal 
extract, DTT, and EGTA, followed by trypsin addition, two VP1-derived tryptic 
digest products termed VP1a and VP1b formed (Figure 2-3A, compare lane 4 to 
3). The VP1b fragment was previously identified as a fragment that lacks the C-
terminus of VP1 and forms only when ERp29 is present within the extract (11). 	  
 
Can ERp57, PDI, or ERp72 functionally replace the chemical reductant DTT? 
mPyV was pretreated with either the redox-inactive calmodulin, ERp57, ERp72, 
or PDI in the presence of EGTA. The samples were then incubated with an ER 
lumenal extract enriched for ERp29, followed by trypsin addition. Our results 
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show that VP1b was generated only when mPyV was pretreated with either 
ERp57 or PDI, but not with calmodulin or ERp72 (Figure 2-3B, compare lanes 2 
and 4 versus lanes 1 and 3). The ERp29-enriched lumenal extract lacks ERp57 
and PDI (Figure 2-3B, compare lane 6 to 5), explaining the requirement of these 
proteins in this reaction. NEM-alkylated ERp57 and PDI were not able to assist 
the lumenal extract in generating VP1b (Figure 2-3C, compare lane 2 to 1 and 
lane 4 to 3). As expected, the catalytic activities of ERp57 and PDI are required 
for replacing DTT to produce VP1b. We conclude that ERp57 and PDI act 
coordinately with ERp29 to extrude the VP1 C-terminal arm. We note that the 
lumenal extract used in this reaction was pretreated with DTT, and the excess 
DTT in the extract removed thoroughly by dialysis (see discussion). 
 
We next investigated if these PDI family members could be isolated in cells as a 
complex or if they partition into distinct compartments within the ER. Cells 
expressing untagged or FLAG-tagged ERp29 were subjected to 
immunoprecipitation with anti-FLAG agarose beads. FLAG-ERp29 precipitates 
also contained detectable amounts of ERp57 (Figure 2-3D, lane 3 versus lane 1 
and 3). PDI and ERp72 were detected similarly (Figure 2-3E). However, these 
interactions were only detected in cells treated prior to lysis with the membrane 
permeable crosslinker dithiobis succinimidylpropionate (DSP). This result 
indicates that the detected interactions are weak and transient or detergent-
sensitive. Nevertheless, ERp29 may exist within a network of other PDI proteins 
to function coordinately. 
 
ERp57 principally isomerizes mPyV, while PDI and ERp72 reduce the virus 
in vitro 
We next assessed the requirement of free thiol groups on the VP1 cysteines of 
mPyV during infection. To this end, mPyV was modified with the alkylating 
reagent NEM (NEM reacts with and irreversibly modifies free thiol groups) or 
mock treated prior to being subjected to a desalting spin column to remove the 
excess reagent. We found that the infection efficiency of the NEM-treated Py was 
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severely attenuated compared to mock, WT Py (Figure 2-4A). Protein unfolding 
or changes in structural integrity can result in an increased sensitivity to 
proteolysis. Limited proteolysis of NEM-treated and WT Py revealed almost 
identical sensitivity to proteinase K (Figure 2-4B, compare lanes 5-8 to lanes 1-
4), suggesting that NEM did not grossly disrupt the structural integrity of the 
virions. Thus, similar to observations with SV40 (17), free cysteines in mPyV are 
critical for infection. 
 
The requirement of free thiol groups on mPyV during entry prompted us to 
investigate if they are utilized by ERp57, PDI or ERp72 for isomerization 
reactions. In disulfide isomerization reactions the intermediate mixed disulfide 
formed between the enzyme and substrate is resolved by a thiol present on the 
substrate. By contrast, a reduction reaction only requires a free cysteine on the 
enzyme to resolve the intermediate. To test whether free cysteines on mPyV are 
required for ERp57 to disrupt viral disulfides, WT and NEM-treated virus were 
incubated with ERp57 and reaction products analyzed as before with 
nonreducing SDS-PAGE. Immunoblot detection of VP1 higher oligomer, 
pentamer, trimer, and to a lesser extent monomer, was diminished markedly 
when ERp57 was incubated with the NEM-treated Py compared to WT Py 
(Figure 2-4C, compare lane 4 to 2). DTT treatment of WT and NEM-treated virus 
produced a similar VP1 monomer level (Figure 2-4C, compare lane 5 to 6), 
demonstrating equivalent amounts of WT and NEM-treated virus was provided in 
the reactions and that both virus types display the same sensitivity to a small 
chemical reductant. We conclude that ERp57 primarily uses an isomerization 
reaction to disrupt VP1 disulfides. 
 
PDI (Figure 2-4D, compare lane 4 to 2) and ERp72 (Figure 2-4E, compare lane 4 
to 2) were observed to generate mPyV-derived species potently regardless of 
whether they were incubated with WT or NEM-treated virus. The prominent 72 
kDa band that appeared in Figure 2-4E (lanes 2 and 4) was also present in a 
sample without Py, indicating that the VP1 antibody used in this immunoblot (i.e. 
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M1) cross-reacts with ERp72. As free cysteines in the Py were not necessary for 
the PDI- or ERp72-dependent reactions, PDI and ERp72 function here as 
reductases. Notably, ERp57 also functions as an isomerase on SV40 (17). 
 
Characterization of the C11A, C15A, and C11A:C15A Py mutants 
Our findings indicate that similar to SV40, mPyV requires free thiols for infection 
and can be isomerized by ERp57. Isomerization of SV40 results in the disruption 
of interpentameric C9-C9 bonds. We asked whether two uncharacterized 
analogous cysteines on mPyV, C11 and C15, were important for infection or 
contributed to capsid stability.  
 
Mutant viruses were produced containing either single or double cysteine to 
alanine mutations of C11 and C15. We first compared their ability to cause 
infection with WT mPyV. When similar amounts of WT and mutant viruses were 
used (Figure 2-5A, lanes 1-4), infection by all three mutants was compromised by 
approximately 50% compared to WT Py (Figure 2-5A, right panel). Limited 
proteolysis demonstrated that all three mutant viruses displayed a similar 
protease sensitivity pattern as WT Py (Figure 2-5B, compare lanes 5-8, 9-12, and 
13-16 to lanes 1-4). Additionally, when subjected to a native agarose gel system 
these mutant virions appeared large and intact as they migrated similarly to WT 
mPyV (Figure 2-5C, compare lanes 2-4 to 1). Next we analyzed the mutant and 
WT mPyV by nonreducing SDS-PAGE. Strikingly, only the C11A:C15A double 
mutant released higher oligomer VP1 products into the gel (Figure 2-5D, 
compare lanes 4 to 2-3). These findings demonstrate that C11 and C15 are 
important during infection and are collectively involved in interpentamer disulfides 
of at least a subset of pentamers. 
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DISCUSSION 
For successful infection of a target host, nonenveloped viruses must penetrate a 
biological membrane to gain access to the cytosol or nucleus. A common theme 
emerging is the role of conformational changes induced to the viral capsid at the 
site of membrane penetration (1, 3). These conformational changes can be 
imparted by a variety of cellular factors including low pH, proteases or 
chaperones. Multiple cellular factors in concert are hypothesized to be needed to 
accomplish structural changes that facilitate penetration. This current study 
provides evidence for multiple ER-resident PDI proteins inducing distinct 
conformational changes to mPyV necessary for ER membrane penetration.  
 
We utilized an siRNA knockdown strategy to assess the importance of three PDI 
family members in mPyV infection of mouse fibroblasts. Loss of ERp57, ERp72 
and PDI individually resulted in a moderate block in infection. Double knockdown 
of multiple PDI proteins blocked infection more severely, implicating these 
proteins as important for mPyV entry. The precise reason for only a moderate 
reduction of infection upon single knockdown is unclear but may be due to 
incomplete knockdown, functional redundancy among PDI proteins or as yet 
undescribed compensatory mechanisms. However, the loss of PDI proteins did 
not cause ER stress supporting their direct role in promoting infection as 
opposed perturbed infection due to global ER dysfunction.  
 
Similar to mPyV, SV40 requires ERp57 and PDI for successful infection (17). 
Interestingly, there appears to be no requirement for ERp72 and ERp29 during 
SV40 infection. While mPyV and SV40 closely share structural characteristics, 
their disulfide bond arrangements are clearly different (14, 16, 25). SV40 
contains two distinct interpentameric disulfide bonds and no intrapentameric 
bonds. The crystal structure of mPyV reveals only an intrapentameric bond. This 
difference between SV40 and mPyV may account for the use of different PDI 
proteins for conformational changes and partial capsid disassembly. The relative 
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concentration of specific PDI proteins within a cell type is also likely to contribute 
to the selection of these host-factors by Pys for membrane penetration. 
 
Using purified components in vitro, we found that ERp57, ERp72 and PDI could 
engage mPyV directly by disrupting disulfide bonds within the capsid. Using a 
nonreducing SDS-PAGE system, VP1 reaction products released from intact 
viruses incubated with PDI proteins could be visualized. These products migrated 
at approximately the size of VP1 monomers, trimers, pentamers and higer 
oligomer species. VP1 monomers could be formed when each intrapentameric 
disulfide is disrupted within a pentamer. In reactions containing ERp57 and 
ERp72 we observed a doublet pattern for monomer sized VP1 products. It is 
unclear exactly how this monomer doublet is formed. The appearance of a 
doublet could represent newly formed intramonomeric disulfide bonds that occur 
during isomerization reactions that are mediated by the enzymes or incidentally 
by free thiols on other VP1 molecules released after initial disulfide disruption.  
 
VP1 trimers but not dimers or tetramers were produced by PDI proteins. The VP1 
trimers released from the viral particle could originate from a single pentamer 
with two intrapentameric disulfide disruptions. Similar to the doublet appearance 
of some monomer products, the trimer species does not migrate at a distinct 
molecular weight. This observation is indicative of a mixture of trimers containing 
different amounts of intramolecular disulfides. VP1 trimers may be more stable 
than tetramers and dimers. VP1 dimers and tetramers may be easily cleaved into 
monomers and trimers respectively by reactive cysteines on PDI proteins or 
newly freed thiols on VP1 itself. Initial disruption of mPyV disulfides may 
influence the accessiblity of other linkages or modify the VP1 surfaces where PDI 
proteins can interact.  
 
Higher oligomer VP1 species may reflect relatively intact viral particles that have 
lost a subset of VP1 pentamers or clusters of VP1 pentamers that remain 
connected but are freed from the bulk of the particle. The latter scenario 
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suggests the presence of interpentameric disulfides, as SDS used in our analysis 
of released VP1 products would disrupt most noncovalent interactions. This 
hypothesis is supported by our mutagenesis study of the uncharacterized C11 
and C15 residues on VP1 (discussed below). 
 
Although each PDI family member analyzed in this study liberated nearly 
identical VP1 products when incubated with mPyV, we identified mechanistic 
differences in their activity. PDI and ERp72 act on mPyV with reductase activity 
while ERp57 principally uses isomerization, a reaction requiring free cysteines on 
the virus. The precise mechanisms used by PDI, ERp72 and ERp57 in promoting 
infection in cells is unknown. Cell based assays monitoring disulfide disruption 
during mPyV entry have been unsuccessful due to the low percentage of viruses 
(5%) reaching the ER from the plasma membrane (6). Alkylated mPyV, which 
cannot be isomerized by ERp57 in vitro, fails to infect cells. We hypothesize that 
ERp57, and possibly other PDI family members, isomerize mPyV in cells similar 
to the required ERp57-mediated isomerization during SV40 entry (17). 
 
Despite the finding that ERp57, PDI, and ERp72 can individually engage mPyV 
to form the virus-derived species, only ERp57 and PDI cooperate with ERp29 to 
unfold the VP1 C-terminal arm (11). This ERp29-induced conformational change 
yields a hydrophobic viral particle competent for membrane binding to initiate 
penetration. Although PDI uses a chaperone activity to cause unfolding of 
cholera toxin (CT) to initiate the toxin’s retrotranslocation into the cytosol (26), the 
catalytic activity of PDI (and ERp57) is instead required to assist ERp29 in 
unfolding the VP1 C-terminal arm. As there are both pentavalent and hexavalent 
pentamers, it is possible that the ERp57-PDI-ERp29 network acts on one of 
these two types, while ERp72 engages the other type. Detection of the ERp29-
mediated conformational change relies on a limited proteolysis approach. 
Therefore, ERp72 may also appear to fail in cooperating with ERp29 if it binds 
and protects the region within VP1 that is normally exposed to trypsin digestion. 
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ERp72 appears to bind tightly to CT to prevent its proteolysis in a similar assay 
(27). 
 
The necessity of multiple chaperone and enzymatic activities for capsid 
remodeling events may be due to the complexity of VP1 arrangement and 
pentamer interfaces on the capsid surface. This asymmetry likely allows the C11 
and C15 residues, which are absent from structural data, to exist in a mixed 
population of oxidized and reduced states. This appears to be true for C104 of 
SV40 which exists in both reduced and disulfide bonded states. We produced 
mutant viruses to characterize C11 and C15 of mPyV. Both single and double 
mutants had reduced infection compared to WT virus. It is unclear why the 
double mutant did not have a more severe defect in infection compared to single 
mutants. This discrepancy may be related to a functional heterogeneity in these 
residues. For example, the double mutant may have a distinct defect from the 
single mutants while obtaining an advantage from bypassing the need to form an 
intermediate. 
 
When analyzed by nonreducing SDS-PAGE, VP1 higher oligomers were 
generated only from the double C11A:C15A mutant. This finding demonstrates 
that C11 and C15 stabilize interpentamer interactions for a subset of the 
pentamers, possibly by forming interpentamer disulfide bonds. If these residues 
do not stabilize all interpentameric interactions because VP1 pentamers would 
appear instead of higher oligomers . Mutating a single cysteine did not generate 
the higher oligomers, indicating that the potential interpentamer disulfide linkages 
could exist between two C11 residues and two C15 residues. C11 on mPyV is 
analogous to C9 of SV40, which forms C9-C9 interpentamer disulfides. Due to 
the two types of pentamer geometries, some pentamers are situated in a 
different local environment than others. While it has not been formally ruled out, 
we consider it unlikely that C11 and C15 stabilize interpentamer contacts in a 
reduced state, coordinating Mg2+ or Ca2+ ions for example. Viruses alkylated with 
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NEM did not release these higher order species when subjected to nonreducing 
SDS-PAGE.  
 
In addition to the PDI proteins described in this study, other ER components may 
act on mPyV to allow the virus to initiate membrane penetration. It is interesting 
to note that in the in vitro trypsin digestion assay, ERp57 or PDI added in 
combination with a reduced ERp29-enriched ER lumenal extract (which lacks 
ERp57 and PDI) generated VP1b. The need for reducing the ERp29-enriched 
lumenal extract in this reaction suggests that ERp29 in the extract must be in the 
reduced form to unfold Py (ERp29 contains one cysteine). Indeed, there is 
precedence for the redox state of a PDI protein controlling its chaperone 
unfolding activity (26, 28). Alternatively, additional reductases or isomerases in 
the extract may be involved in producing a penetration-competent viral particle. 
Further experiments are required to distinguish these possibilities. 
 
In conclusion, our study highlights a complex interplay between viral cysteine 
residues of mPyV and host reductases, isomerases, and chaperones of the PDI 
family. These reactions promote transport of the virus from the ER into the 
cytosol, a pivotal infection step. The versatility of PDI family members to engage 
a complex endogenous proteome may be the reason why Pys have evolved to 



















Figure 2-1. Downregulation of ERp57, ERp72, and PDI Reduces mPyV 
Infection 
	  
(A) Knockdown of PDI family members. NIH 3T3 cells were transfected with the 
indicated siRNA, and lysates derived from the cells subjected to SDS-PAGE and 
immunoblotted with the indicated antibodies. 	  
(B) Induction of XBP1 splicing. RT-PCR analysis of the unspliced (u) and spliced 
(s) forms of the XBP1 mRNA from cells treated with DTT, tunicamycin, or 
transfected with the indicated siRNA. 	  
(C) Py infection in the knockdown cells. Cells transfected with scrambled siRNA, 
or one of two independent siRNAs against ERp57, ERp72, and PDI (siRNA #1 
and #2) were challenged with Py (100 PFU/cell), and the large T antigen 
expression was analyzed by standard immunofluorescence microscopy. Values 
were normalized to scrambled siRNA. Data represent the mean +/- SD of at least 
three independent experiments. 	  
(D) As in A, except the indicated siRNAs were used. 	  
(E) As in B, except the indicated siRNAs were used. 	  
(F) As in C, except the indicated siRNAs were used. 	  















Figure 2-2. ERp57, PDI, and ERp72 Disrupt Disulfide Bonds on mPyV in 
vitro 
 
(A) Expression and purification of ERp57, PDI, and ERp72. N-terminally His-
tagged ERp57, PDI, and ERp72 constructs were expressed in bacteria, purified 
to homogeneity, and subjected to Coomassie staining.  
(B) ERp57 acts on mPyV directly. Where indicated, purified mPyV were 
incubated with ERp57, heat-treated ERp57, or NEM-treated ERp57. The 
samples were subjected to nonreducing SDS-PAGE and immunoblotted with an 
“I-58” VP1 antibody. * indicates a non-specific band recognized by the VP1 
antibody. 	  
(C) As in B, except mPyV was pretreated at pH 5. 	  
(D) PDI acts on mPyV directly. PDI or NEM-treated PDI was incubated with or 
without purified mPyV and analyzed as in (B). 	  
(E) As in D, except mPyV was pretreated at pH 5. 	  
(F) ERp72 acts on mPyV directly. ERp72 or NEM-treated ERp72 was incubated 
with or without purified mPyV and analyzed as in (B). 	  






















Figure 2-S1. ERp57, PDI, and ERp72 can Disrupt Disulfide Bonds on mPyV 
Under Conditions Mimicking ER Redox 
 


















Supplementary Figure 2. 
ERp57, PDI, and ERp72 disrupt Py’s disulfide bonds in a condition that mimics the ER redox state.












































Figure 2-3. ERp57 and PDI Function Coordinately with ERp29 to Unfold 
mPyV in vitro 	  
	  
(A) VP1 digestion pattern. Crude mPyV was incubated with DTT, EGTA and 
either BSA or an ER lumenal extract followed by trypsin addition, where 
indicated. The samples were subjected to SDS-PAGE followed by 
immunoblotting with a VP1 antibody. 	  
(B) Purified mPyV was pretreated with either calmodulin, ERp57, ERp72, or PDI 
in the presence of EGTA. The samples were then incubated with an ERp29-
enriched ER lumenal extract, added with trypsin, subjected to SDS-PAGE, and 
immunoblotted with a VP1 antibody. 10% input for the amount of ERp57, PDI, 
and the ERp29-enriched ER lumenal extract used are shown. 	  
(C) As in B, except NEM-treated ERp57 and PDI were used where indicated.  
(D) NIH 3T3 cells transfected with either a rat ERp29 or an N-terminally FLAG-
tagged rat ERp29 construct were treated with or without the DSP crosslinker. 
The resulting cell lysates were subjected to immunoprecipitation using an 
antibody directed against the FLAG epitope conjugated to agarose. The 
precipitates, as well as the cell lysates (input), were subjected to SDS-PAGE and 
immunoblotted with antibodies against ERp57 and ERp29.  

















Figure 2-4. ERp57 Principally Isomerizes mPyV, while PDI and ERp72 
Reduce the Virus in vitro 
 
(A) Free cysteines in mPyV are required for infection. NIH 3T3 cells were 
incubated with either WT or NEM-treated mPyV (100 PFU/cell), and the infection 
efficiency analyzed as in Figure 2-1C.  
(B) NEM-treated virus is not grossly misfolded. WT and NEM-treated mPyV were 
incubated with the indicated concentrations of proteinase K, and the samples 
subjected to SDS-PAGE and immunoblotted with a VP1 antibody.  
(C) ERp57 largely isomerizes mPyV. WT or NEM-treated mPyV was incubated 
with ERp57 or DTT (where indicated), and the samples analyzed by nonreducing 
SDS-PAGE followed by immunoblotting with a VP1 antibody.  
(D) PDI reduces mPyV directly. As in (C), except PDI was used instead of 
ERp57.  
(E) ERp72 reduces mPyV directly. As in (C), except ERp72 was used instead of 




















Figure 2-5. Characterization of the C11A, C15A, and C11A:C15A mPyV 
Mutants 
 
(A) VP1 C11 and C15 are important for mPyV infecion. NIH 3T3 cells were 
incubated with a similar level of crude WT mPyV, mPyV (C11A), mPyV (C15A), 
or mPyV (C11A:C15A), and the infection efficiency analyzed as in Figure 2-1C. 
(B) Mutant viruses are not misfolded globally. Viruses in (A) were subjected to 
limited proteolysis as in Figure 2-4B. 	  
(C) Native agarose gel analyses of mutant mPyV. Viruses in (A) were subjected 
to 0.4% native agarose gel, transferred to a nitrocellulose membrane, and 
immunoblotted with an antibody against VP1. 	  
(D) VP1 C11 and C15 mediate inter-pentamer interaction for a subset of the 
pentamers. Viruses in (A) were subjected to nonreducing and reducing SDS-
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Chapter 3: Cytosolic Chaperones Complex with Dynamic Membrane              




Nonenveloped viruses must penetrate a biological membrane to infect cells. As 
they lack a surrounding lipid bilayer, membrane penetration by nonenveloped 
viruses must be fundamentally different from enveloped viruses, which normally 
gain access to the host cell by membrane fusion. Although the precise 
membrane transport mechanism for nonenveloped viruses is not entirely clear, a 
general principle is emerging. These viruses enter host-cells by endocytic 
internalization in order to arrive at a precise cellular environment necessary for 
productive infection (1). Upon reaching this proper environment, important 
conformational changes are induced by specific cellular triggers including low pH, 
proteases, or chaperone activities (2). These conformational changes in turn 
generate a hydrophobic viral particle or cause the release of a lytic peptide 
hidden in the intact virus. Engagement of the hydrophobic particle or lytic peptide 
with the limiting membrane disrupts the membrane integrity and initiates 
membrane penetration. For example, the nonenveloped reovirus, parvovirus, and 
adenovirus become internalized and traffic to endosomes where the low pH or 
proteases trigger viral conformational changes that allow them to penetrate the 
endosomal membrane (3-6). In these cases, membrane penetration is thought to 
involve virus-induced pore formation or disruption of overall membrane integrity. 
Currently, absent in this model is a role for any cytosolic factors directly 
influencing membrane penetration. 
 
Polyomaviruses are unique among nonenveloped viruses in that they traffic 
beyond the endosomal system to reach the endoplasmic reticulum (ER) for 
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membrane penetration (7-13). This virus family consists of a growing list of 
important human polyomaviruses known to cause devastating diseases in 
immunocompromised individuals (14, 15). Simian virus 40 (SV40) has 
traditionally served as an excellent model member of this family; it has genetic 
and structural similarity to human polyomaviruses, yet is easy to propagate and 
study in cells. To cause infection, SV40 engages the ganglioside receptor GM1 
at the cell surface to initiate internalization (16, 17). Caveolae-dependent 
endocytosis brings SV40 particles attached to lipid rafts into the cell where they 
travel through endosomes before being sorted to the ER (7, 12). Once inside the 
ER lumen, SV40 is faced with the task of penetrating the ER membrane to reach 
the cytosol prior to nuclear import (18, 19). In the nucleus, transcription and 
replication of the viral genome take place, leading to production of new viral 
particles. 
 
The ER provides an ideal environment for inducing important conformational 
changes to the structure of SV40. The outer surface of each viral particle 
contains 360 copies of the major coat protein VP1 arranged as 72 pentamers 
(20, 21). A single hydrophobic minor coat protein VP2 or VP3 resides beneath 
each VP1 pentamer (22). SV40 VP1 molecules are stabilized by interpentameric 
disulfide bonds, with bound calcium ions and hydrophobic interactions providing 
additional capsid support (20). Protein disulfide isomerase (PDI)-family members 
appear to be broadly important during entry of polyomaviruses for either their 
ability to disrupt viral disulfide bonds by using their redox/isomerase activities, or 
to impart conformational changes by using their chaperone functions (10, 23-26). 
PDI proteins exert these activities on SV40, likely in concert with other ER 
factors, resulting in VP2 exposure (11, 27, 28). Due to its hydrophobic N-
terminus, exposure of VP2 renders the virus itself hydrophobic (28). As a result, 




In the next stage of the membrane penetration process, a critical Glu residue in 
VP2’s N-terminus embedded in the ER membrane is hypothesized to act as a 
charged irregularity in the ER membrane and recruits cellular factors involved in 
ER-associated degradation (ERAD) (29). The ERAD pathway utilizes large multi-
protein complexes to eliminate misfolded or incorrectly assembled ER proteins 
by facilitating their retro-translocation into the cytosol for degradation by the 
ubiquitin-proteasome system (30, 31). SV40 and other polyomaviruses co-opt 
several ERAD membrane components including the J-proteins DnaJB14 (B14) 
and DnaJB12 (B12) to reach the cytosol and infect cells (8, 26, 32, 33). B14 and 
B12 both span the ER membrane once and display their functional J domain in 
the cytosol (34-36). By virtue of this domain, J-proteins stimulate the ATPase 
activity of Hsp70 chaperones to promote substrate-Hsp70 interaction. However, 
the precise mechanism by which these membrane components facilitate ER-to-
cytosol transport of a large viral particle is not clear. Whether any cytosolic 
components provide the driving force to extract the hydrophobic ER membrane-
embedded SV40 into the cytosol is also unknown. In this context, the cytosolic 
ATPase p97 (also called VCP) involved in the mobilization of ERAD substrates 
into the cytosol was shown to be dispensable for SV40 infection (29, 37). 
Additionally, while chemical inhibition of the cytosolic proteasome perturbs SV40 
infection (8, 26, 38, 39), this effect may be indirect (29). Thus, the potential roles 
of cytosolic factors that directly promote membrane penetration of 
polyomaviruses, as well as other nonenveloped viruses, remain enigmatic. 
 
Here, we demonstrate that the cytosolic chaperone SGTA is critical for transport 
of SV40 from the ER membrane into the cytosol. SGTA associates with a 
chaperone complex containing B14 and B12 (B14-B12) at the ER membrane and 
is therefore positioned to act at the site of membrane penetration. Using a 
combination of cell-based and biochemical assays, we found that SGTA binds 
directly to SV40 and promotes its ER membrane penetration and infection. 
During membrane penetration, SGTA is released from the B14-B12 complex, 
suggesting SV40 alters localization or structural characteristics of these factors. 
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Consistent with this idea, we found that SV40 causes the B14-B12 complex to 
reorganize into discrete foci in the ER membrane. As formation of these foci 
coincides temporally with SV40’s cytosolic arrival, they may represent ER exit 





























MATERIALS AND METHODS 
 
Antibodies 
Polyclonal DnaJB14, DnaJB12, ERdj5, SGTA, Hrd1 were purchased from 
Proteintech Group (Chicago, IL). An additional rabbit polyclonal against SGTA 
was provided by Yihong Ye (NIH). Monoclonal BAP31 and polyclonal Hsc70 and 
Bag6 antibodies were purchased from Pierce (Rockford, IL). Polyclonal Derlin-1 
and Sec61α antibodies were provided by Tom Rapoport (Harvard University). 
Normal rabbit and mouse IgG, polyclonal Hsp90, PDI, and monoclonal SV40 
Large T antigen antibodies were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA). Rabbit anti-VP1 antibody was a gift from Harumi Kasamatsu 
(UCLA). Monoclonal VP1 antibody was provided by Walter Scott (University of 
Miami). Monoclonal p97 was purchased from RDI/Fitzgerald (Concord, MA). 
Polyclonal BiP, mouse anti-GAPDH and rat anti-Hsc70 antibodies were 
purchased from Abcam (Cambridge, MA). Polyclonal calnexin antibodies were 
purchased from Stressgen. Polyclonal ERp29 was a gift from Souren Mkrtchian 
(Karolinska Institutet).  
 
Reagents 
Dulbecco’s modified Eagle’s medium (DMEM), Opti-MEM, 0.25% trypsin-EDTA 
were purchased from Invitrogen (Carlsbad, CA). Fetal Clone III (FC) was from 
HyClone (Logan, UT). Complete-mini EDTA-free protease inhibitor cocktail 
tablets were purchased from Roche. Micro Bio-Spin P-30 Tris chromatography 
columns were purchased from Bio-Rad. Dithiothreitol (DTT), Dithiobis 
succinimidylpropionate (DSP), N-ethylmaleimide (NEM) and anti-FLAG M2 
agarose beads were purchased from Sigma (St Louis, MO).  
 
Preparation of SV40 
WT SV40 and ΔVP2 SV40 were prepared using OptiPrep gradient system as 
described previously (39). 
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Transfection of siRNA and DNA Plasmids 
Control siRNA (labeled as scrambled) is the All Star Negative purchased from 
Qiagen (Valencia, CA). Custom siRNA sequences were generated and 
purchased from Dharmacon (Pittsburgh, PA).  
 
SGTA siRNA #1: 5’GGUAGAAGACAGUGACCUUUU3’ 
       5’AAGGUCACUGUCUUCUACCUU3’ 
SGTA siRNA #2: 5’ACAAGAAGCGCCUGGCCUAUU3’ 
      5’UAGGCCAGGCGCUUCUUGUUU3’ 
Bag6 siRNA #1: 5’GCUUGGAGGUGUUGGUGAAUU3’ 
       5’UUCACCAACACCUCCAAGCUU3’ 
Bag6 siRNA #2: 5’GAUAAGAAGCUUCAGGAAUUU3’ 
       5’AUUCCUGAAGCUUCUUAUCUU3’ 
 
Using Lipofectamine RNAiMAX (Invitrogen), 25 nM of control or custom siRNAs 
were reverse transfected into HeLa or CV-1 cells. Infection or biochemical assays 
were carried out 24 or 48 h.p.i.. A plasmid expressing human WT DnaJB14 was 
a gift from Daniel DaMaio (Yale) and cloned with an N-terminal FLAG tag into 
pcDNA3.1 minus (Invitrogen). Site-directed mutagenesis was performed on 
His136 to yield a H136Q mutant. The Δlumenal FLAG-B14 contains residues 1-
282 and Δcytosol contains residues 226-379, and were generated using standard 
cloning methods. A plasmid expressing SGTA-myc/FLAG is from Origene 
(Rockville, MD) and double point mutants were derived similarly by site-directed 
mutagenesis. DNA was transfected into plated CV-1 cells (50-80% confluent) 
using FuGENE and allowed to express for 18-24 h prior to experimentation. 
 
B14-B12 and SGTA Co-immunoprecipitations 
Interactions detected between endogenous B14 and B12 utilized lysates derived 
from CV-1 or HeLa cells with buffer containing 50 mM Tris pH 7.4, 150 mM NaCl, 
1 mM EDTA and protease inhibitors with 1% deoxyBigCHAP (Calbiochem, 
Billerica, MA). Cleared lysates were incubated with antibodies overnight at 4°C 
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with rotation. Antibodies were captured using protein A agarose beads and 
washed with lysis buffer containing 0.1% deoxyBigCHAP. SDS sample buffer 
was used for elution at 95°C. Interactions between endogenous SGTA and B14-
B12 were detected similarly but with a different lysis buffer. 293T or CV-1 cells 
were lysed by resuspension and brief vortexing in 0.1% digitonin, 50 mM Tris, 
150 mM NaCl, 1 mM EDTA and protease inhibitors followed by incubation on ice 
for 15 minutes. Cleared lysates were incubated with indicated antibodies, 
captured with protein A agarose beads and washed extensively with buffer 
lacking detergent. Immunoprecipitation of transfected SGTA-myc/FLAG was 
performed as above but with a buffer containing 0.2% digitionin and incubation 
with anti-FLAG M2 agarose beads. 
 
SGTA-SV40 Co-immunoprecipitations 
In 6 cm plates, 3 x 105 CV-1 cells were transfected to express FLAG-tagged GFP 
or SGTA proteins for at least 18 h. SV40 particles (15 µg) were added to cells 
after synchronizing the entry at 4°C. Approximately 8 h.p.i., cells were harvested 
and cross-linked using 2 mM DSP at room temperature for 30 mins. After 
quenching, cells were lysed in 1% Triton X-100, 50 mM Tris pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 20 mM NEM and protease inhibitors. Cleared lysates were 
immunoprecipitated with anti-FLAG agarose beads overnight and washed 3 
times with lysis buffer. Bound material was analyzed by immunoblotting using 
rabbit anti-VP1 antibody. 
 
XBP1 Splicing Assay 
As previously described (25) using primers against human XBP1:  
5’- CGCGGATCCGAATGTGAGGCCAGTGG-3’ and  
5’- GGGGCTTGGTATATATGTGG-3’. 
 
Gel Filtration Chromatography 
HeLa cells were lysed in 1% Triton, 30 mM Tris pH 8, 150 mM NaCl, and 4 mM 
MgCl2. Cleared lysates were separated using lysis buffer and a Bio-Sil SEC 250 
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column (Bio-Rad, Hercules, CA). Forty fractions of 0.5 mL were collected and 
fractions 10-22 were analyzed by immunoblotting. 
 
Preparation of Purified Proteins 
For purification of FLAG-tagged GFP, WT and mutant SGTA, 293T cells were 
transfected to express proteins for 48 h. Cells were lysed in buffer containing 1% 
Triton X-100, 50 mM Tris, 150 mM NaCl, 1 mM EDTA and protease inhibitors. 
Cleared lysates were incubated with anti-FLAG agarose beads and bound 
proteins washed extensively with lysis buffer. Proteins were eluted with FLAG 
peptide overnight and concentrated using centrifugal filters that also removes 
residual FLAG peptides. Optiprep purified SV40 was treated with 3 mM DTT and 
10 mM EGTA for 45 min at 37°C to mimic ER induced conformational changes. A 
spin column was used to exchange the buffer with PBS and to remove DTT and 
EGTA.  
 
In Vitro Binding Assays 
Binding reactions were carried out in 50 mL PBS containing 250 ng of SV40 
(pretreated with DTT and EGTA as described above) with or without 1 mg of 
purified protein. Reactions incubated for 1 h at 25°C followed by the addition of 
0.25 mM DSP at 4°C for 30 min to stabilize transient interactions. After 
quenching with excess Tris, immunoprecipitation with anti-FLAG agarose beads 
was performed and bound material analyzed by immunoblotting. 
 
Immunofluorescence Microscopy for Foci Formation 
CV-1 cells were grown on 12 mm coverslips in 6 or 24-well plate for 24 h. Cells 
were treated with SV40 for the indicated time and then washed in PBS followed 
by fixation with 1% formaldehyde at room temperature. Cells were permeabilized 
with 0.2% Triton X-100 and blocked with 5% milk and 0.2% Tween. Primary 
antibodies were incubated for 1 h at room temperature, followed by fluorescent 
conjugated secondary antibodies for 30 min at room temperature. Cover slips 
were mounted with ProLong Gold (Invitrogen). Images were taken using an 
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inverted epifluorescence microscope (Nikon Eclipse TE2000-E) equipped with 
60x and 100x 1.40 NA objective and a Photometrics CoolSnap HQ camera. For 
over-expression studies, cells were transfected with the desired plasmid with 
FuGene (Promega) at least 24 h prior to imaging. For live-cell imaging, cells are 
seeded on 35mm glass bottom tissue culture dishes (Greiner Bio-one, Germany). 
Imaging of the cells was performed from 2 to 20 h.p.i. using the microscope and 
objective mentioned above. The entire set-up was controlled by MetaMorph 
software (Molecular devices) and ImageJ software (NIH) was used for image 
processing, analysis, and assembly. 
 
SV40 and BKPyV Infection Assay 
CV-1 cells transfected with siRNA for 24 h were incubated with SV40 at 37°C 
(M.O.I. 3-10). At 20-24 h.p.i., cells were harvested for analysis by immunoblot or 
fixed and stained using antibodies against SV40 large T antigen as described 
previously (39). For each infection experiment, at least 500 cells were counted in 
each condition. Approximately 30-50% cells were positive for Large T antigen in 
the control conditions.  
 
Purified BKPyV and pAb416 against BK large T antigen were provided by 
Michael Imperiale (University of Michigan). CV-1 cells transfected with siRNA for 
24 h were infected at M.O.I. ≈ 1. Cells were harvested after 40 h.p.i., and 
immunoblot performed for large T antigen. 
 
ER-to-cytosol Transport and ER Arrival Assays 
Performed as in (39). SV40 was added (M.O.I ≈ 10) to CV-1 cells grown in 6 cm 
plates (~80% confluent). Where indicated, BFA (Epicenter, Madison, WI) was 
added to the media at 2.5 mg/mL. After fractionation, 40% of the supernatant 
fraction was compared alongside 10% of the pellet fraction for immunoblot 
analyses, as only a portion of SV40 reaches the cytosol. Fractionation markers 
were analyzed with equivalent amounts of supernatant and pellet. Image J 
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software was used for quantification of VP1 band intensities. ER arrival assays 
were performed as described previously (39). 
 
Immunopurification of B14 Binding Partners 
Flp-In T-REx 293 cells (Invitrogen) were transfected with a pcDNA5/FRT/TO 
plasmid expressing WT B14-3xFLAG along with pOG44 plasmid expressing a 
Flp recombinase. Selection was carried out with media containing hygromycin 
and blasticidin over several weeks. Expression of B14-3xFLAG to near 
endogenous levels was induced with 5 ng/mL of tetracycline provided to the 
media for 16 h. Three confluent 15 cm plates were collected in PBS and lysed for 
30 mins on ice in 2.5 mL of buffer containing 0.1% digitonin, 50 mM Tris pH 7.4, 
150 mM NaCl, 1 mM EDTA and protease inhibitor. Lysate was cleared with 
centrifugation at 20,000g for 15 min. Lysate divided in half was incubated for 2 h 
at 4°C with 30 mL of anti-FLAG M2 agarose beads that was pre-incubated with 
or without 3xFLAG peptide (100 mL, 0.25 mg/mL). Agarose beads were washed 
extensively with buffer lacking detergent. Bound proteins were eluted overnight at 
4°C with 3xFLAG peptide (200 mL, 0.25 mg/mL). Three subsequent elutions 
were performed for 1 h each, pooled and concentrated using centrifugal filters 
(Amicon Ultra 0.5 mL 3K membrane). SDS sample buffer was added and heated 
for 30 min at 37°C followed by SDS-PAGE and silver staining or immunoblotting. 
Bands excised from a silver stained gel were analyzed by mass spectrometry at 
Taplin Biological Mass Spectrometry Facility (Harvard Medical School). 
 
Statistics 
Quantitative data is presented as the mean of at least three independent 
experiments with standard deviation. Paired two-tailed Student’s t-tests were 







B14 Forms a High Molecular Weight Complex with B12 
To clarify how B14 and B12 promote SV40 ER membrane penetration (32), we 
first characterized their biochemical properties. Gel-filtration analysis of 
detergent-solubilized cell extracts followed by subsequent immunoblotting of the 
individual fractions demonstrate that a substantial pool of B14 eluted in high-
molecular weight fractions (>150 kDa), suggesting B14 is part of a complex 
larger than its monomeric size of 42 kDa (Figure 3-1A). Probing for Hrd1 and 
ERp29 confirmed the fractionation of large and small complexes, respectively. 
B12 co-fractionated identically with B14, raising the possibility that these proteins 
interact with each other. Co-immunoprecipitation experiments revealed that 
endogenous B14 and B12 bind to each other with high efficiency in both HeLa 
and CV-1 cells (Figure 3-2B and 3-2C). These data demonstrate that these J-
proteins interact with each other and are likely part of a stable membrane 
complex. 
 
The Cytosolic Chaperone SGTA Binds to the B14-B12 Complex in a Hsc70-
dependent Manner 
To identify other components of the B14 complex, we used an unbiased strategy 
of immunoprecipitation followed by mass spectrometry (MS). We constructed 
293T cells that allowed for tetracycline-inducible expression of B14-3xFLAG. To 
minimize overexpression artifacts, B14-3xFLAG expression was maintained at a 
level similar to endogenous B14 by providing a low concentration of tetracycline 
(Figure 3-2A). Under this condition, cells were lysed with a low concentration of 
digitonin to maintain protein-protein interactions during immunoprecipitation with 
anti-FLAG conjugated agarose beads. To control for nonspecific binding to the 
agarose beads, an identical lysate was incubated with anti-FLAG conjugated 
agarose beads pre-blocked with 3xFLAG peptide. After washing and elution by 
addition of 3xFLAG peptide, the eluted material was concentrated and subjected 
to SDS-PAGE followed by silver staining (Figure 3-2B). Co-immunoprecipitated 
proteins reproducibly observed by silver staining were excised and analyzed by 
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MS. Not surprisingly, a band migrating at approximately 72 kDa was identified as 
Hsc70, a common interacting partner of J-proteins. Interestingly, another band 
corresponding to approximately 38 kDa was identified as the cytosolic chaperone 
SGTA. We focused our study on this protein as it was recently implicated in the 
ERAD pathway (40). While several components of the SMN complex involved in 
spliceosomal snRNP assembly and pre-mRNA processing were also identified 
during MS analyses, they remain to be tested as authentic B14 binding partners. 
Eluted samples prepared as in Figure 3-2B were immunoblotted with specific 
antibodies to confirmed the presence of SGTA, Hsc70, and B14-3xFLAG (Figure 
3-2C). Importantly, when endogenous SGTA was immunoprecipitated from 
standard 293T or CV-1 cells, endogenous B14 but not the abundant membrane 
protein BAP31 was detected in the precipitate (Figure 3-2D, left and right 
panels). As B12 complexes with B14 (Figure 3-1), we asked whether 
endogenous B12 also binds SGTA. Indeed, B12 also co-precipitated with SGTA. 
(Figure 3-2D, right panels).  
 
We asked whether B14-B12 binding to SGTA was mediated by any known 
interacting partners of SGTA. Previously SGTA has been observed to interact 
with Hsc70 as a co-chaperone (41, 42). Additionally, a more recent study 
demonstrated that SGTA binds to the cytosolic Bag6 (BAT3, scythe)-Ubl4a-Trc35 
complex via Ubl4a (40). We therefore tested whether SGTA mutants defective in 
their ability to bind to either Hsc70 (K160E/R164E) or Ubl4a (D27R/E30R) could 
interact with B14. CV-1 cells were transfected to express FLAG-tagged WT or a 
mutant form of SGTA. Lysates derived from these cells were immunoprecipitated 
with anti-FLAG conjugated agarose beads. Endogenous B14 was observed to 
precipitate with WT-SGTA and the Ubl4a-binding defective mutant (D27R/E30R) 
(Figure3- 2E). By contrast, the Hsc70-binding defective mutant (K160E/R164E) 
was unable to interact with B14, despite substantially more mutant in the 
precipitation when compared to WT SGTA (Figure 3-2E). This interaction was 
specific to B14’s cytosolic J-domain as ERdj5, a lumenal J-protein, did not 
precipitate with any form of SGTA (Figure 3-2E). We performed the converse 
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analysis by transfecting FLAG-tagged WT B14 or a mutant B14 defective in 
coupling to Hsc70 (H136Q)(34). WT B14 but not H136Q B14 precipitated 
endogenous SGTA (Figure 3-2F). Together these data demonstrate SGTA 
interacts with the B14-B12 complex in a Hsc70-dependent manner. 
 
Downregulation of SGTA Perturbs SV40 and BKPyV Infection 
B14 and B12 are two key ER membrane components crucial for SV40 and 
human BK polyomavirus (BKPyV) infection (32). Since our findings revealed 
SGTA is a binding partner of the B14-B12 complex, we first asked whether SGTA 
was important for SV40 infection.  Expression of the virally-encoded large T 
antigen protein in the host nucleus reflects successful viral infection. We 
monitored infection in this way by scoring cells for the presence or absence of 
large T antigen using immunofluorescence microscopy. Two distinct siRNA 
oligonucleotides effectively downregulated SGTA expression in both CV-1 and 
HeLa cells (Figure 3-3A). Under these knockdown conditions, cells appeared 
healthy as determined by their overall morphology and number when compared 
to cells transfected with scrambled siRNA. Downregulation of SGTA in both cell 
types reduced SV40 infection by approximately 50% when compared to cells 
transfected with a scrambled siRNA (Figure 3-3B). Similarly, these knockdown 
conditions markedly reduced the expression of BKPyV large T antigen as 
assessed by immunoblot analyses (Figure 3-3C). Neither upregulation of the ER 
stress markers BiP, PDI, and Derlin-1 (Figure 3-3C), nor pronounced stimulation 
of XBP-1 slicing (Figure 3-3D) was observed when SGTA was silenced, 
indicating no significant induction of ER stress occurred within the time frame of 
our experiments. This result varies from a recent report where a cell line stably 
expressing SGTA shRNA exhibits an ER stress response. This difference may 
be due to our use of a transient knockdown. We conclude that SGTA plays an 
important and specific role during SV40 and BKPyV infection.  
 
SGTA is involved in multiple aspects of protein quality control. Recent evidence 
suggests one function of SGTA is to facilitate ERAD substrate loading on Bag6, a 
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holdase that prevents substrate aggregation prior to proteasomal degradation. 
Based on these findings, we tested whether Bag6 was important for SV40 
infection and found that Bag6 knockdown did not block expression of SV40 large 
T antigen (Figure 3-S1), indicating that SGTA promotes SV40 infection 
independent of Bag6. 
 
SGTA Promotes ER-to-cytosol Transport of SV40 
As SGTA is a cytosolic chaperone complexed with the ER membrane J-proteins 
B14 and B12, we asked whether this chaperone facilitates the arrival of SV40 
into the cytosol from the ER. Our laboratory previously developed a cell-based 
assay to monitor SV40 ER-to-cytosol transport (39). A similar assay has also 
been reported (29). Briefly, cells infected with SV40 are harvested, selectively 
permeabilized with a low digitonin concentration, and centrifuged to generate a 
supernatant and a pellet fraction; the supernatant harbors cytosolic material while 
the pellet contains intracellular membranes including the ER. These fractions are 
subsequently analyzed by immunoblotting for fractionation markers and VP1. 
VP1 in the supernatant therefore represents SV40 that reached the cytosol, and 
VP1 in the pellet reflects virus within intracellular organelles. We applied this 
assay to cells transfected with scrambled or SGTA siRNAs. The cytosolic 
markers GAPDH and Hsp90 were predominantly detected in the supernatant 
whereas the ER lumenal markers PDI and ERp29 were found exclusively in the 
pellet (Figure 3-3E), confirming the integrity of the fractionation procedure. 
Strikingly, the VP1 level in the supernatant was significantly reduced in cells with 
SGTA downregulated when compared to scrambled control (Figure 3-3E; 
quantified in 3-3F). We note that the severity in the ER-to-cytosol transport defect 
appears to be greater than the perturbation in infection (Figure 3-3B). This 
difference is likely attributed to the low virus level present in the cytosol under 




We also assessed whether downregulating SGTA affects arrival of SV40 to the 
ER. Successful SV40 ER arrival can be monitored by examining the amount of 
Triton X-100 soluble VP1 present in the pellet (i.e. membrane fraction). We 
previously found that only viruses which arrive in the ER are released from Triton 
X-100 insoluble lipid rafts into the ER lumen whose content can be extracted by 
Triton X-100. As expected, when cells were infected in the presence of Brefeldin 
A (BFA), there was a robust block in ER arrival of SV40 due to disruption of 
intracellular retrograde trafficking (Figure 3-3G). However, no detectable loss of 
SV40 ER arrival was found using SGTA siRNA #2 while only a modest loss in the 
ability of SV40 to reach the ER when SGTA siRNA #1 was used (Figure 3-3G). 
Thus SGTA does not significantly regulate retrograde trafficking of SV40 to the 
ER. Given that a pool of SGTA resides on the cytosolic side of the ER membrane 
due to its interaction with B14 and B12, we propose this factor facilitates SV40 
infection primarily by completing the membrane penetration step during entry.  
 
SGTA Dissociates From the B14-B12 Complex During SV40 Entry 
If SGTA extracts SV40 from the ER membrane into the cytosol, we reasoned that 
SGTA itself might dissociate from the B14-B12 complex during virus transport. 
We first monitored SGTA-B14 interaction using co-immunoprecipitation assays 
during SV40 entry. Cells were uninfected or infected for 2 or 8 h, harvested, 
followed by cross-linking of the intact cells. Similar to previous experiments 
(Figure 3-2D), when endogenous SGTA was immunoprecipitated, a significant 
amount of B14 was detected (Figure 3-4A). This interaction remained intact at 2 
h post infection (h.p.i.) (Figure 3-4A), a time point when SV40 particles are 
largely present in endosomes and have not yet reached the ER. By contrast, a 
stable SGTA-B14 interaction was completely lost at 8 h.p.i. (Figure 3-4A) when 
SV40 has reached the ER and initiated ER-to-cytosol transport. When Hsc70 
was immunoprecipitated under similar conditions, a loss of stable B14 interaction 
was also detected (Figure 3-4B). However, the interaction between Hsc70 and 
SGTA was mostly preserved. These data indicate that during time points of entry 
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where SV40 is undergoing membrane penetration, SGTA and Hsc70 are being 
released from the B14-B12 complex at the ER membrane. 
 
This phenomenon held true in CV-1 cells transfected to express FLAG-tagged 
GFP or FLAG-tagged SGTA (Figure 3-4C); when cells uninfected or infected for 
16 h were lysed and immunoprecipitated using anti-FLAG agarose beads, stable 
interactions between transfected SGTA and endogenous B14 as well as B12 
remained disrupted at this later time point.  While membrane penetration is 
observed to begin between 6 and 8 h.p.i., this process likely continues at later 
times due to the asynchronous nature of SV40 entry. 
 
Our time point analyses suggested that SV40 penetration across the ER 
membrane is required to release SGTA from the B14-B12 complex. To further 
test this hypothesis, we utilized a mutant SV40 lacking VP2 (i.e. ΔVP2 SV40). 
This mutant virus becomes internalized but fails to penetrate the ER membrane 
to reach the cytosol. When compared to WT SV40, ΔVP2 SV40 did not disrupt 
the interaction of SGTA and B14-B12 (Figure 3-4D). Together, our findings 
indicate that the initiation of ER membrane penetration by SV40 is required for 
release of SGTA from the B14-B12 complex.  
 
We assessed whether this dissociation event was general for ER bound cytosolic 
chaperones or specific to SGTA. The cytosolic p97 chaperone is well 
documented to link to ERAD complexes at the ER membrane and facilitate retro-
translocation of ERAD substrates. In cells infected with SV40, p97’s interaction 
with the ERAD membrane component Derlin-1 was unchanged (Figure 3-4E). 
This result is consistent with the recent finding that p97 is not required for SV40 
entry and infection(29). SV40 infection also did not disrupt endogenous B14-B12 
interaction (Figure 3-4E). We conclude SV40 specifically triggers SGTA to be 
released from the B14-B12 complex without globally disrupting the connection of 
cytosolic factors to the ER membrane. 
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SGTA Associates with SV40 During Entry in Cells and In Vitro 
An additional explanation to account for the release of SGTA from B14-B12 is 
that SGTA disengages from B14-B12 in order to engage SV40 as it becomes 
exposed in the cytosol. To test this possibility, CV-1 cells were transfected to 
express FLAG-tagged SGTA and infected for 8 h followed by cross-linking and 
immunoprecipitation with anti-FLAG agarose beads. Indeed, VP1 was detected 
in the immunoprecipitate of infected cells (Figure 3-4F). By contrast, VP1 was not 
detected in infected cells treated with BFA, which blocks ER arrival and 
subsequent transport to the cytosol (11, 39) (Figure 3-4F). Thus, SGTA binds to 
SV40 upon cytosolic arrival. We next investigated whether this SV40-SGTA 
interaction required the Hsc70-dependent localization of SGTA to the B14-B12 
complex. When cells transfected with FLAG-tagged GFP, WT SGTA or the 
K160E/R164E SGTA mutant were infected and subjected to 
immunoprecipitation, VP1 was observed to co-precipitate only with WT SGTA 
and not GFP or K160E/R164E SGTA (Figure 3-4G). This result suggests that 
localization of SGTA to the B14-B12 complex via Hsc70 is required for SGTA to 
engage the virus during entry. 
 
Hsc70 has been reported to associate with polyomaviruses in vitro and in cells 
during both entry and de novo capsid assembly. To assess whether SGTA binds 
to SV40 directly or requires Hsc70, we tested whether the SGTA-SV40 
interaction could be recapitulated in vitro using purified components. FLAG-
tagged GFP, WT SGTA and K160E/R164E SGTA were purified from transfected 
293T cells. WT but not GFP or K160E/R164E SGTA copurified Hsc70 (Figure 3-
4H). These purified components were incubated with purified SV40 pretreated 
with DTT and EGTA to partially mimic conformational changes that occur in the 
ER. When GFP or SGTA proteins were immunoprecipitated from these reactions, 
VP1 was detected only in reactions containing SGTA (Figure 3-4I). WT SGTA 
pulled down moderately more VP1 when compared to K160E/R164E SGTA, 
likely due to the presence of Hsc70 in the WT SGTA preparation. Nonetheless, 
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the observation that purified K160E/R164E SGTA lacking copurified Hsc70 binds 
to VP1 demonstrates that SGTA can directly interact with SV40.  
 
SV40 Induces the B14-B12 Complex to Form Foci on the ER Membrane 
Our finding that SV40 liberates SGTA and Hsc70 from the B14-B12 complex 
suggests that the virus may restructure B14-B12 within the ER membrane. To 
assess whether SV40 imparts any reorganization of B14-B12, we stained 
endogenous proteins in fixed cells uninfected or infected with SV40 for analysis 
by immunofluorescence microscopy. In uninfected cells, both B14 and B12 co-
localized extensively with the ER membrane protein BAP31 (Figure 3-5A and 3-
5B, top panels), as expected. Strikingly, in infected cells, a significant portion of 
B14 and B12 was observed to concentrate into discrete foci within the ER (Figure 
3-5A and 3-5B, lower panels). Some cells were observed to contain a single 
focus, while others contained several. Notably, B14 and B12 foci co-localized 
with VP1 (Figure 3-5C and 3-5D), suggesting that SV40 is responsible for foci 
formation. As reported previously, BAP31 also reorganizes into foci during SV40 
infection (29). We found that virus-induced BAP31 foci co-localized with the B14 
and B12 foci (Figure 3-5A and 3-5B). These results indicate that, while B14-B12 
and BAP31 were identified independently to be critical for SV40 membrane 
penetration, they are likely to be unified in facilitating this entry step rather than 
functioning in distinct parallel pathways. 
 
The localization of Sec61α, a major translocon component reported to associate 
with BAP31 (44), remained diffuse and unchanged by addition of SV40 (Figure 3-
S2A, top panels). Similarly, Hrd1 staining revealed it did not form foci upon SV40 
infection (Figure 3-S2A, middle panels). Although Hrd1 is a central component of 
ERAD machinery (45, 46), it is dispensable for SV40 entry and infection. 
Consistent with our observation that SGTA disengages from B14-B12 during 
entry, we did not detect any SV40-induced enrichment of SGTA in the B14-B12-
BAP31 foci (Figure 3-S2A, bottom panels). These data indicate that SV40 
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induces the reorganization of only a specific subset of ER membrane proteins 
into a discrete region. 
 
We observed that knockdown of SGTA did not inhibit foci formation (Figure 3-
S2B), indicating that SGTA acts independently or downstream of foci formation. 
We further characterized SV40-induced foci formation by performing time course 
experiments where the presence or absence of this structure was monitored 
during infection by staining with specific antibodies after fixation (Figure 3-5E). 
When cells were infected for 2 h, foci were not detected. After 8 and 12 h of 
SV40 infection, approximately 25-70% of cells contained B12, B14, and BAP31 
foci. By 16 h, nearly every cell was positive for B12, B14, and BAP31 foci. BFA 
strongly inhibited foci formation. Moreover, we used live cell imaging to monitor 
foci formation in cells transiently transfected to express GFP-tagged B14 (GFP-
B14). GFP-B14 was observed to gradually re-organize into clear foci at 
approximately 5-6 h after the addition of SV40 (Figure 3-5F). We conclude that 
SV40-induced reorganization of B14-B12 and other membrane components is 
dependent on ER arrival of the virus, occurs approximately 5-6 h.p.i., and is 
largely irreversible. The timing of SV40’s cytosolic arrival (39) correlates strongly 
with our detection of foci in the ER membrane, therefore we postulate that these 
virus-induced structures are ER exit/cytosol entry sites for the virus.  
 
B14 Requires its Lumenal Domain for SV40-induced Foci Formation 
We sought to identify the molecular determinants of B14 necessary for SV40-
induced B14 foci formation. When full length FLAG-tagged B14 was transfected 
into CV-1 cells and stained as before, the transfected protein co-localized 
extensively with BAP31 in a diffuse manner (Figure 3-6A, left panels). When cells 
were infected, the ectopically expressed FLAG-B14 formed foci similar to the 
behavior of endogenous B14 (Figure 3-6A, right panels), with variable number of 
foci per cell observed. Comparable to endogenous B14 foci (Figure 3-5A), the 




As transfected WT B14 forms foci in response to SV40, we then asked whether 
transfected mutant forms of B14 are capable of forming foci during SV40 
infection. Transfected H138Q B14, which does not interact with Hsc70 or SGTA, 
formed foci identical to WT B14 (Figure 3-6B, first and second row). Truncating 
most of B14’s lumenal domain (97 amino acids) to generate Δ lumenal B14 
strongly restricted it’s ability to form foci, despite this mutant co-localizing 
normally with BAP31 in the absence of SV40 (Figure 3-6B, third row and 
quantified in Figure 3-6C). In addition to the normal ER expression pattern, this 
mutant also precipitated endogenous B12 and SGTA, demonstrating the overall 
integrity of this variant (Figure 3-S3). By contrast, a severe truncation of B14’s 
cytosolic residues (i.e. Δ cytosol B14) did not restrict foci formation, acting similar 
to the full length WT B14 (Figure 3-6B, fourth row). Expression of the FLAG-B14 
variants had minimal influence on the ability of endogenous BAP31 to form foci 
and did not perturb infection, likely due to the presence of endogenous B14 
(Figure 3-6D). We conclude that the lumenal domain of B14 is required for its 
SV40-triggered reorganization into foci and potentially acts as a sensor for the 
virus directly. 
 
B14-mediated Chaperone Recruitment and Foci Formation is Required to 
Promote Infection. 
We assessed the molecular requirements of B14 in promoting SV40 infection by 
performing rescue experiments. HeLa cells were chosen for these experiments 
because of their high transfection efficiency. DNA plasmids were first transfected 
for expression from an empty vector, WT B14, H138Q B14 or Δ lumenal B14. 
Subsequently siRNA transfections were carried out using an siRNA oligo 
targeting the 3’ UTR sequence of B14 to ensure depletion of only endogenous 
B14. After 48 h of siRNA treatment, cells were incubated with SV40 and 
successful infection measured 2 days later by immunoblotting for TAg (Figure 3-
7). Infection of cells expressing empty vector as a control presented a complete 
loss of TAg expression upon B14 knockdown compared to scrambled siRNA. 
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This phenotype was reversed significantly in cells expressing WT B14. By 
contrast, H138Q B14 and Δ lumenal B14, while expressed at appropriate levels, 
failed to support infection in cells depleted of endogenous B14 (Figure 3-7). 
These data support a model whereby B14’s ability to recruit Hsc70-SGTA is 
necessary for SV40 infection. The inability of Δ lumenal B14 to form foci and 
promote infection suggests that foci are functionally important for SV40 as well.
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DISCUSSION 
To cause infection, nonenveloped viruses penetrate a biological membrane to 
gain access into the target cell. While host cues priming these viruses for 
membrane penetration are well-characterized, cytosolic factors co-opted to 
complete this membrane penetration event remain unknown. In this study, we 
pinpoint SGTA as a cytosolic chaperone that promotes membrane penetration of 
SV40 and likely other polyomaviruses. A model depicting SGTA-dependent SV40 
ER membrane penetration is presented in Figure 3-8. 
 
Our initial finding revealed that a pool of SGTA binds to the cytosolic surface of 
the ER membrane by engaging two transmembrane J-proteins called B14 and 
B12 (Figure 3-8A), essential factors for SV40 ER-to-cytosol transport and 
infection (32). Interaction between SGTA and the B14-B12 complex requires 
Hsc70, a cytosolic chaperone central to global cellular proteostasis, and is 
consistent with previous reports demonstrating that SGTA interacts with Hsc70 
(42). The interaction of SGTA with the B14-B12 complex prompted us to ask 
whether it might serve to dislocate SV40 into the cytosol from the ER membrane. 
Indeed, our functional studies demonstrated that SGTA downregulation disrupts 
SV40 and BKPyV infection by blocking virus ER-to-cytosol transport, with 
subsequent binding experiments establishing a direct SGTA-SV40 physical 
interaction. These results suggest that SGTA engages the virus on the cytosolic 
surface of the ER membrane to mobilize it into the cytosol.  
 
The use of SGTA to liberate SV40 into the cytosol from the ER membrane 
resolves a previous enigma in the mechanism of ER membrane penetration by 
SV40(47). Structural alterations occuring within the ER render the virus 
hydrophobic, enabling it to bind to and integrate into the ER membrane(28, 29). 
Despite these remodeling events, SV40 remains a large and intact particle when 
it penetrates the ER membrane (39). How this large and hydrophobic viral 
particle avoids aggregation in the aqueous cytosolic environment is unclear. 
Particle aggregation would clearly prevent SV40 from successfully reaching the 
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nucleus to cause infection. One possibility entails cytosolic chaperones 
positioned next to the ER membrane binding to and extracting the hydrophobic 
virus into the cytosol, and by use of this interaction, protecting the hydrophobic 
viral surfaces. Our results support this scenario by implicating SGTA, a cytosolic 
chaperone that binds to hydrophobic proteins (40), in mobilizing the virus into the 
cytosol and concomitantly protecting the viral hydrophobic surfaces.  
 
Although SGTA has been recently linked to the ER-to-cytosol transport process 
known as ERAD, its apparent role in this instance is to assist the Bag6 complex 
in capturing ERAD substrates in the cytosol and preventing their aggregation 
prior to proteasomal degradation (40, 48). By contrast, a separate study found 
that SGTA antagonizes Bag6 function during protein quality control in the cytosol 
(49). Regardless of their relationship, SGTA appears to promote SV40 infection 
independently of Bag6. Our data reveals that SGTA likely serves additional 
undocumented roles in ER biology, possibly in cooperation with B14-B12.  
 
We observed that SGTA and Hsc70 disengage from the B14-B12 complex, an 
event that coincides with the drastic reorganization of the B14-B12 complex into 
concentrated foci on the ER membrane (Figure 3-8B). It is possible that smaller 
foci structures, which are not clearly detected by microscopy, also exist to 
mediate viral transport. This would explain why a stable SGTA-B14 interaction 
appears fully disrupted at time points where not all cells have visible foci. 
The energy source driving release of the virus-SGTA-Hsc70 complex into the 
cytosol is not known. It is possible that virus-induced B14-B12 foci formation 
imparts a conformational change that weakens the affinity between B14-B12 and 
SGTA-Hsc70. Alternatively, foci formation may simply be used to transiently 
increase the local chaperone concentration at the penetration site, allowing 
efficient engagement of the virus. While SGTA itself does not harbor ATPase 
activity, it can modulate the ATPase activity of Hsc70 (41). Thus, if SV40 binding 
to SGTA promotes SGTA to drive Hsc70 preferentially to the ADP-bound state, 
ADP-bound Hsc70 would have lower affinity for its cognate J-proteins B14 and 
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B12 (50, 51). This postulated scenario could explain how SV40 triggers release 
of SGTA-Hsc70 from B14-B12. Future experiments will clarify the precise 
mechanism by which SV40 induces SGTA and Hsc70 to disengage from the 
B14-B12 complex. Nonetheless, discharge of the SV40-SGTA-Hsc70 complex 
into the cytosol from the ER membrane (Figure 3-8C) is conceptually consistent 
with SV40’s requirement to reach the cytosol in preparation for nuclear import 
during infectious entry. As Hsc70 proteins are observed to disassemble murine 
polyomavirus in vitro (52), polyomaviruses entering a host-cell could in principle 
co-opt both SGTA and Hsc70 activities to couple the cytosol release and viral 
disassembly reactions, with the latter likely being necessary for subsequent 
nuclear import.  
 
The B14-B12 foci were positive for VP1, similar to a previous report that found 
VP1 co-localizes with BAP31 foci (29). Foci likely contain multiple viruses and 
future work will attempt to assess the presence of VP1 quantitatively. As ER 
membrane penetration is an inefficient process (39), only a small fraction of virus 
in the foci are expected to be released into the cytosol, explaining why VP1 
accumulates in the foci even at later time points. These foci unlikely represent 
nonproductive, aggregation structures as no dramatic changes in the solubility of 
the B14 and B12 membrane proteins were observed during foci formation. 
Moreover, B14-B12 foci co-localize with BAP31, another ER membrane factor 
involved in SV40 ER membrane penetration, but not with other membrane 
proteins dispensable for SV40 infection such as a core ERAD component Hrd1 
(29). Thus foci consist of specific ER factors that conduct SV40 across the ER 
membrane but not ER components irrelevant to this process. Intriguingly, there 
was a strong temporal correlation between foci formation and virus arrival in the 
cytosol. Foci formation can be readily identified prior to 8 h.p.i. and SV40 cytosol 
arrival occurs between approximately 6-8 h.p.i (29, 39). We therefore propose 
that the B14-B12 foci represent cytosol entry sites that function to increase the 
local SV40 concentration precisely at the membrane penetration site where the 
properly positioned SGTA can efficiently bind to and extract the virus into the 
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cytosol. This model is supported by our findings that B14 requires its ability to 
recruit chaperones and form foci to promote infection.  
 
Virus-induced foci formation and other changes to ER morphology is likely to be 
common among Pys. BKPyV was recently observed to localize to specific 
subdomains within the ER (38). Addition of proteasome inhibitor blocked infection 
by BKPyV and caused viruses to localize away from BiP-rich regions of the ER 
and instead colocalize with Calnexin. These results suggest that engagement by 
BiP may be critical for productive infection by BKPyV. 
 
A direct interaction between SV40 and B14-B12 or BAP31 has yet to be 
demonstrated, possibly due to a weak affinity of these factors to the particle 
within the membrane. This weak physical interaction could also explain the 
necessity of foci formation, which would facilitate multivalent interactions among 
several membrane components functioning to promote membrane penetration. 
At present, the relationship between B14-B12 and BAP31 remains obscure. 
Although these membrane proteins form foci in response to SV40 entry, no 
obvious physical interaction between B14-B12 and BAP31 can be isolated. 
Moreover, while BAP31 is thought to recognize membrane integrated SV40 with 
exposed VP2 via charge-pairing (29), both B14 and B12 lack charged residues 
within their transmembrane domains and thus recognize SV40 differently. In this 
regard, by evaluating different B14 mutants, we found that the lumenal portion of 
B14 is required for its SV40-induced reorganization. This region of B14, which 
lacks any clear protein-protein interaction domains, could therefore act as a 
sensor for engaging SV40 complementarily with BAP31.   
 
An outstanding question is whether a bona fide protein-conducting channel exists 
to accommodate SV40 transport across the ER membrane. If this is the case, it 
is unlikely that a native channel can support the transport of such a large viral 
particle whose diameter is approximately 45-50 nm. Instead, the hydrophobic 
virus might initially integrate into the membrane and subsequently recruit and 
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oligomerize ER membrane proteins such as B14, B12, and BAP31. The 
oligomerized structure (i.e. foci) would surround the viral particle until SGTA-
Hsc70 extracts it into the cytosol.  
 
In conclusion, this study identifies a novel cytosolic chaperone complex that 
completes ER membrane penetration of a nonenveloped virus, and utilizes 
dramatic rearrangement of ER membrane elements in the process. Viral entry, 
replication, and assembly are defining steps during the infection course. While 
diverse viruses are known to rearrange the ER membrane to facilitate viral 
replication and assembly, essentially nothing is known regarding how viruses 
reorganize the ER membrane during entry (53). The possibility that SV40 and 
other polyomavirus family members might reorganize components of the ER 
membrane to fashion its own entry site would demonstrate that viruses have the 
























Figure 3-1. B14 complexes with B12.  
 
(A) Lysates prepared from HeLa cells were subjected to gel filtration 
chromatography. Collected fractions were analyzed by immunoblot with the 
indicated antibodies.  
(B) B14 and B12 interact. HeLa cell lysates were used for immunoprecipitation 
with control IgG or antibodies against endogeneous B12 or B14.  

































Figure 3-2. The Cytosolic Chaperone SGTA Binds to the B14-B12 
Complex in a Hsc70-dependent Manner.  
 
(A) B14-3xFLAG is expressed at a level near endogenous B14. Whole cell 
lysates derived from Flpn-293 TREx(B14-3xFLAG) were analyzed by SDS-
PAGE and immunoblotted with an antibody against B14. Relative molecular 
weight markers in kDa are shown on the right.  
(B) SGTA identified by MS as a binding partner of B14. Immunopurified B14-
3xFLAG complexes from lysate in (A) was eluted by 3xFLAG peptide and 
subjected to SDS-PAGE and silver staining. A control experiment was 
performed in which lysate was incubated with anti-FLAG agarose beads pre-
incubated with 3xFLAG peptide. Indicated proteins were identified after band 
excision using MS. * indicates a protein migrating at the size of B14-3xFLAG. 
(C) As in (B) except immunoblotting was performed with the indicated 
antibodies. 
(D) Endogenous interaction between SGTA and B14-B12. Lysates derived 
from 293T (left) or CV-1 cells (right) were used for immunoprecipitation with 
the indicated antibodies.  
(E) SGTA’s interaction with B14 requires coupling to Hsc70. CV-1 cells were 
transfected with plasmids expressing FLAG-tagged WT or SGTA mutants. 
Immunoprecipitation was performed from the cell lysates using anti-FLAG 
agarose beads with subsequent immunoblot analysis.  

























Figure 3-3. SGTA Knockdown Perturbs SV40 and BKPyV Infection by 
Blocking Viral ER-to-cytosol Transport 
 
(A) CV-1 (left) or HeLa cells (right) were transfected with scrambled or 
siRNAs targeting SGTA for 24 h before being harvested and analyzed by 
immunoblotting with the indicated antibodies.  
(B) SGTA knockdown blocks SV40 infection. Cells transfected for 24 h as in 
(A) were infected with SV40 for 20-24 h, fixed, and stained for large T 
antigen. Infection was scored using immunofluorescence microscopy 
(counting ≥500 cells for each condition). CV-1 cells were infected at a MOI ≈ 
3, resulting in 30-50% cells positive for large T antigen. HeLa cells were 
infected with SV40 at a MOI≈10, resulting in 3-5% cells infected for the 
control condition. Infection was normalized to scramble siRNA and represents 
the mean ± SD of at least three independent experiments. A statistically 
significant (p < 0.05) difference was observed with all SGTA knockdown 
conditions compared to scrambled.  
(C) SGTA is important for BKPyV infection. CV-1 cells transfected as in (A) 
were infected with BKPyV at a MOI ≈1. Lysates were subjected to 
immunoblotting with the indicated antibodies 40 h.p.i.  
(D) XBP1 splicing does not occur with transient SGTA knockdown. RT-PCR 
analysis of the unspliced (u) and spliced (s) forms of XBP1 mRNA in cells 
transfected with scrambled or SGTA siRNAs. Where indicated, cells were 
treated with DTT as a positive control for UPR induction.  
(E) SGTA promotes ER-to-cytosol transport of SV40. CV-1 cells transfected 
as in (A) were incubated with SV40 at a MOI ≈10, harvested 12 h.p.i. and 
subjected to ER-to-cytosol transport assay (see experimental procedures).  
(F) Relative VP1 band intensities in the supernatant fractions were 
determined using ImageJ (NIH). Data are normalized to scrambled siRNA. 
Only experiments with equal loading (Hsp90 or GAPDH) were considered. 
Values represent the mean ± SD of four independent experiments. A 
statistically significant (p < 0.05) difference was observed with all SGTA 
knockdown conditions compared to scrambled.  
(G) Loss of SGTA does not significantly block ER arrival of SV40. Pellet 
fraction produced from cells as in (E) were solubilized in a buffer containing 
1% Triton X-100. After centrifugation, the soluble fraction was analyzed by 
VP1 immunoblotting. As a positive control, where indicated, cells were treated 







Figure 3-S1. Bag6 Knockdown does not Block SV40 Infection, Related to 
Figure 3-3 
 
CV-1 cells were transfected with the indicated siRNAs for 24 h before being 
infected with SV40 for an additional 24 h and harvested. Immunoblot analysis 













Figure 3-4. SGTA-Hsc70 Dissociates from the B14-B12 Complex and 
Engages SV40 During Entry 
 
(A) Endogenous SGTA is released from B14 during entry. CV-1 cells were 
uninfected or infected with SV40 at a high MOI (≈100) for the indicated time. 
Cells were harvested, cross-linked, and lysed in buffer containing 1% Triton 
X-100 followed by immunoprecipitation with SGTA antibodies and 
immunoblotting. 
(B) Endogenous Hsc70 is released from B14 during entry. CV-1 cells were 
infected or uninfected for 12 h and immunoprecipitated as in (A) except 
Hsc70 antibodies were used. 
(C) Transfected SGTA is released from B14-B12 during entry. CV-1 cells 
transfected to express FLAG-tagged GFP or SGTA were infected with SV40 
for 16h. Immunoprecipitation was performed without cross-linking and the 
precipitated material analyzed by immunoblotting. 
(D) SV40 lacking VP2 fails to trigger dissociation of SGTA from B14-B12. As 
in (B) except cells were also infected with ΔVP2 SV40. 
(E) p97-Derlin-1 interaction is unaffected by SV40. Cells infected with virus as 
in (A) were lysed without cross-linking and immunoprecipitated with the 
indicated antibodies with subsequent immunoblotting of the precipitated 
material. 
(F) SGTA interacts with SV40 in cells during entry. CV-1 cells transfected to 
express FLAG-tagged WT SGTA were infected with SV40 at high MOI. 
Where indicated, cells were treated with BFA. Cells were cross-linked, lysed, 
and immunoprecipitated with anti-FLAG agarose beads. Precipitated proteins 
were analyzed by immunoblotting with the indicated antibodies.  
(G) SGTA requires localization to B14-B12 for interaction with SV40. As in (E) 
except cells were transfected to express either FLAG-tagged GFP, WT SGTA 
or mutant SGTA. 
(H) Coomassie staining of purified proteins isolated from transfected 293T 
cells. 
(I) Direct binding of SGTA and SV40 in vitro. Purified proteins were incubated 
with DTT/EGTA-treated SV40. Reactions were cross-linked, and the sampled 























Figure 3-5. SV40 Induces the B14-B12 Complex to Form Foci on the ER 
Membrane 
 
(A) B14 reorganizes into foci upon SV40 infection. CV-1 cells uninfected or 
infected with SV40 (MOI ≈ 30-50) for 16 h were fixed and stained with the 
indicated antibodies for immunofluorescence microscopy. 
(B) B12 reorganizes into foci upon SV40 infection. As in (A) except B12 
antibodies were used. 
(C) VP1 is present in B14-B12 foci. As in (A) using B14 and VP1 antibodies. 
(D) As in (C) except using B12 antibodies. 
(E) Time course experiment monitoring foci formation. Cells were infected as 
in (A). Where indicated, BFA was added during entry. Cells were fixed at 
different time points after infection and stained with antibodies against 
BAP31, B14, or B12. Cells were scored positive if at least one focus is 
present in the cell. Values represent mean ± SD of three independent 
experiments. 
(F) Live cell imaging of GFP-B14 foci formation. Cells were transfected to 
express B14 with an N-terminal GFP tag. Cells were infected with SV40 and 
live cell imaging performed beginning at 2.5 h.p.i. Numbers in each frame 












Figure 3-S2. Foci do not Contain Sec61α, Hrd1 and SGTA, and are 
Unaffected by Loss of SGTA, Related to Figure 3-5. 
 
(A) CV-1 cells were infected with SV40 for 16 h before being fixed and stained 
with the indicated antibodies for immunofluorescence microscopy. 
(B) CV-1 cells were transfected with scramble or SGTA siRNAs prior to addition 
of SV40. 16 h.p.i., cells were fixed and stained for BAP31. Cells were scored for 
the presence or absence of foci. Data are normalized to the scramble condition 
and represent the mean ± SD of three independent experiments. No statistical 












Figure 3-6. B14 Requires Its Lumenal Domain for SV40-induced Foci 
Formation 
 
(A) Transfected WT FLAG-B14 forms SV40-induced foci. Cells were 
transfected with empty vector or a plasmid expressing WT FLAG-B14. Cells 
were uninfected or infected with SV40 for 16 h, fixed, and stained with 
antibodies for immunofluorescence microscopy. 
(B) Δlumenal FLAG-B14 fails to reorganize into foci. Cells were transfected 
with WT or mutant FLAG-B14 and analyzed as in (A). 
(C) Quantification of (B). Fixed cells were scored for the presence or absence 
of FLAG-foci in cells expressing the respective FLAG-tagged protein. Values 
represent mean ± SD of three independent experiments. A statistically 
significant (p < 0.05) difference was observed with Δlumenal FLAG-B14 when 
compared to all other versions of FLAG-B14. 
(D) BAP31 foci formation is not disrupted by expression of WT or mutant B14. 
As in (C) except cells were scored for BAP31 foci in cells expressing the 
indicated FLAG-tagged protein. Values represent mean ± SD of three 




















Figure 3-S3. B14 Mutant Lacking Lumenal Domain Interacts with B12 and 
SGTA, Related to Figure 3-6 
 
CV-1 cells were transfected to express FLAG-tagged B14 mutant or left 
untransfected. Lysates were prepared and immunoprecipitation carried out using 


























Figure 3-7. B14-mediated Chaperone Recruitment and Foci Formation is 
Required to Promote Infection. HeLa cells were transfected with the indicated 
DNA plasmids for approximately 18 h prior to transfection with scrambled or B14 
siRNA. SV40 was incubated with cells for 2 days before preparing whole cell 




















Figure 3-8. Model for ER-to-Cytosol Transport of Polyomaviruses 
Mediated by Foci Formation and Cytosolic SGTA 
 
(A) Polyomaviruses become hydrophobic due to conformational changes 
imposed upon them by ER lumenal chaperones and PDI proteins. This 
hydrophobicity allows for membrane binding and integration by the viral 
particle. 
(B) Membrane-bound viruses recruit the B14-B12 complex causing their 
reorganization into discrete foci, which may serve to transiently increase the 
local concentration of chaperones at the site of membrane penetration. 
(C) Polyomaviruses are mobilized out of the ER into the cytosol in a SGTA-
dependent manner. SGTA and Hsc70 are released from the B14-B12 
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Chapter 4. Conclusions and Future Directions 
A conceptual overview of this thesis is presented in Figure 4-1. The membrane 
penetration events that allow Pys to infect a host-cell relies on multiple PQC 
networks existing in the ER lumen, membrane and cytosol. Py transport to the 
cytosol appears analogous in many ways to the pathway used for the elimination 
of misfolded ER proteins.  
 
The hijacking of cellular PQC systems by nonenveloped viruses and other 
pathogens has evolved as a strategy for several reasons. First, PQC systems 
exist with a functional versatility that allows for the proper folding, translocation, 
and degradation of a diverse and complex proteome. This versatility is highly 
suitable for recognition of foreign viruses during both entry and assembly, as 
productive protein-protein interactions and conformational changes are often 
critical for these events. Secondly, chaperones and other quality control factors 
are positioned in nearly every cellular space to maintain proteostasis with high 
efficiency. In the context of membrane penetration by viruses, the utilization of 
membrane-localized chaperone networks existing normally for translocation into 
or out of organelles may be underappreciated.  
 
The use of ER resident PDI proteins by polyomaviruses during entry (Chapter 2) 
illustrates how PQC factors can be exploited for their versatility. PDI proteins are 
involved in both the biogenesis and destruction of proteins (1, 2). Many PDIs 
have established chaperone activity (2-5), allowing them to bind hydrophobic 
stretches of proteins to minimize aberrant interactions to promote proper folding. 
The oxidoreductase activity of PDI proteins is carried out by thioredoxin domains 
containing C-x-x-C motifs (6). This enzymatic activity permits the disulfide 
oxidation, reduction and isomerization of newly synthesized or misfolded 
proteins. Formation or rearrangement of disulfides (i.e. oxidation and 
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isomerization) can confer stability and proper folding of newly synthesized 
proteins entering the ER. By contrast, reduction of disulfides can correct 
mistakes in disulfide formation and is hypothesized to maximize the efficiency of 
retrotranslocation and degradation of some misfolded ER proteins. In these 
cases, the disruption of disulfide bonds exposes a degradation signal or 
produces a more unstable substrate allowing recognition by degradation 
machinery (7-9). For interchain linkages, disulfide bond disruption reverses the 
multimerized state of a substrate prior to retrotranslocation (10).  
 
mPyV appears to use enzymatic and chaperone activities of PDI proteins to 
become ‘activated’ for the initiation of membrane penetration (11-13). Previous 
studies, together with research described in Chapter 2, suggest that activation 
occurs in a series of reactions. ERp57, ERp72 and PDI can disrupt disulfides that 
stabilize the mPyV capsid structure. According to crystallographic data, a 
disulfide bond between two cysteines serves to reinforce the interpentameric 
interaction between VP1 C-termini (14). Disruption of this bond is likely a 
prerequisite for ERp29-induced conformational changes, which involves the 
extrusion of VP1 C-termini from neighboring pentamers and ultimately the 
exposure of hydrophobic VP2 proteins (12, 13). Consistent with this, the assay 
utilized for monitoring ERp29-dependent VP1 conformational changes requires 
addition of a reductant such as DTT for full activity(13). In vitro experiments 
presented in Chapter 2 demonstrate that catalytic activities of ERp57 and PDI 
can functionally replace DTT. From these results it appears that isomerase 
(ERp57) or reductase (PDI) activity allows for chaperone (ERp29) conformational 
changes that lead to a hydrophobic viral particle. Chaperone activities of these 
PDI proteins, as well as other factors, could also be used to maintain the 
solubility of the hydrophobic virus during targeting to the ER membrane. Thus, 
the various actions of PDI proteins working in a coordinated fashion leads to 
productive membrane penetration by mPyV. 
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The precise actions of ERp57, PDI and ERp29 which facilitate mPyV infection 
have not yet been demonstrated in vivo. Furthermore, the specific role of ERp72 
(which does not functionally replace DTT in vitro) in promoting mPyV infection is 
unclear but may involve its chaperone or catalytic activity or both. Cell based 
assays that monitor conformational changes would prove useful for dissecting 
specific PDI roles during mPyV entry. However, the low percentage of viral 
particles reaching the ER limits the sensitivity and robustness of this strategy 
(15). Another unanswered question is whether PDI proteins also act to release 
the ganglioside-bound Pys into the lumen of the ER. Is this an upstream event or  
one concomitant with VP2 exposure? A Py particle must be released from the 
ganglioside receptors prior to reaching the cytosol. Optimally, this receptor-
detachment step would involve the same conformational changes required for 
transport across the ER membrane. An assay that exploits detergent solubility 
differences between ganglioside-bound viruses in lipid rafts and released 
lumenal viruses is suitable for exploring this nuance. 
 
ERp29 downregulation does not inhibit SV40 infection in HeLa cells (16). It is 
unknown what factor(s) within the ER cause VP2 exposure for SV40. It is 
possible that the interpentameric disulfide disruption is sufficient for VP2 
exposure and membrane binding. Future studies should examine if ERp57 or 
other factors are involved in SV40 VP2 exposure using in vitro and cell based 
approaches. Nevertheless, the versatility of PDI family members appears to be 
utilized extensively during Py entry. 
 
Cellular proteins require their correct conformation and localization to function 
properly. To achieve and supervise this, PQC systems assisting in the protein 
folding, transport and appropriate turnover are distributed widely throughout the 
cell. This ubiquity serves pathogens an opportunity to utilize these systems 
wherever needed for conformational changes or transport events. For example, 
Pys encounter PDI proteins in the ER lumen for conformational changes and 
ERAD machinery localized at the ER membrane for transport to the cytosol. The 
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findings presented in Chapter 3 reveal that cytosolic chaperones recruited by ER 
membrane proteins also function in the membrane penetration of SV40 and likely 
other polyomaviruses. This is the first report providing evidence that cytosolic 
chaperones can be utilized by nonenveloped viruses for membrane penetration. 
 
Chaperone networks could also be utilized for membrane penetration by other 
nonenveloped viruses that are not trafficked to the ER but instead penetrate from 
the endolysosomes. For example, it is speculated that reovirus uses Hsc70 
during endosomal membrane penetration (17), however this remains to be 
formally tested. A population of Hsc70 is described to reside on the cytosolic side 
of the lysosomal membrane to function in recruiting and translocating substrates 
of chaperone-mediated autophagy (CMA) into this digestive compartment (18). 
Cochaperones, including J-proteins, are not yet described in CMA but could also 
be co-opted with Hsc70, analogous to SV40 utilizing B14-B12 and SGTA at the 
ER membrane. 
 
SGTA appears to have a variety of cellular functions as a cochaperone of heat 
shock proteins (19-21). Likely to be the most relevant for Py entry is the recent 
observation that SGTA is active during ERAD (22). Again as part of a complex, 
SGTA functions to promote solubility of dislocated ER proteins. This is achieved 
by aiding in substrate capture by the cytosolic holdase Bag6, which interacts with 
gp78, a core membrane component of ERAD (23). Cells with reduced levels of 
SGTA or Bag6 contain large aggregates of the canonical ERAD substrate TCRα, 
an unassembled transmembrane protein. Additionally, in vitro experiments reveal 
that SGTA and Bag6 preferentially bind unfolded proteins and can suppress the 
aggregation of denatured luciferase. Currently there is no clear evidence that 
SGTA promotes the solubility of cytosol-localized Pys. Future research should 
attempt to examine this possibility further. 
 
Upon discovering that SGTA promotes ER-to-cytosol transport of SV40, the 
possibility that Bag6 was important for this process was also tested. Unlike SGTA 
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the downregulation of Bag6 by siRNA did not affect infection. This result may 
indicate that a pool of SGTA has a normal cellular function at the ER membrane 
outside of the Bag6-associated role and that Bag6 is not important for infection. 
Analogously, when ERp57 was identified to be important for SV40 infection (16), 
it too appeared to be acting outside of its canonical function (i.e. in association 
with CNX and CRT, both of which are dispensable for SV40 infection).  
 
While recently described to function in ERAD as a holdase, Bag6 was initially 
discovered to mediate cytosolic proteostasis. Specifically, Bag6 is central to the 
transmembrane recognition complex (TRC)-mediated biosynthetic pathway for 
membrane insertion of tail-anchored (TA) proteins and may provide a function 
similar to Sgt2p in the analogous GET (guided entry of TA proteins) pathway in 
yeast (24). These factors are involved in a cascade of hand-off reactions 
between chaperones that ultimately target and insert hydrophobic TA proteins 
into the ER membrane. As knockdown of Bag6 did not perturb SV40 infection, 
newly synthesized TA proteins may also be dispensable for SV40 entry. 
However, stable preexisting TA proteins could still be utilized by the virus for 
various steps of entry, including internalization, vesicular transport or membrane 
penetration. 
 
The native function of SGTA-Hsc70 complexed with B14 and B12 is unknown 
and an important question. B14 and B12 are both implicated as factors promoting 
ERAD of the membrane substrate CFTR. SGTA’s role in protein degradation is 
currently limited to recruiting dislocated substrates to the Bag6 holdase. It is 
possible that SGTA is functioning with B14-B12 during ERAD in parallel to its role 
with Bag6. In experiments monitoring ERAD, the utilization of SGTA mutants that 
favor interaction with one complex over another could help resolve this question. 
Alternatively, as GEMIN proteins and related factors were identified as putative 
binding partners of B14 there may be a functional connection with RNA biology 
and spliceosome assembly. A more rigorous screen for overlapping binding 
partners of B14-B12 and SGTA will provide additional insight. 
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Considering the ubiquity of PQC factors, what determines which factors are 
selected for use by an evolving Py? The answer to this question is not entirely 
clear. One possibility is related to one hypothesis regarding the selection of 
misfolded proteins for degradation among others that are unfolded but en route 
to a proper conformation. Importantly, some factors involved in folding also 
moonlight with a role in degradation. This suggests a mechanism where some 
proteins can be targeted for degradation stochastically. For example, PDI aids in 
the productive folding and degradation of proteins yet interacts weakly with 
membrane bound ERAD component Derlin-1(25). If a substrate is terminally 
misfolded it will have prolonged interactions with PDI and therefore have an 
increased chance of remaining bound to PDI during complex formation with 
Derlin-1. This might explain why toxins and viruses that breach the ER 
membrane co-opt soluble PQC units that have direct physical interactions with 
membrane bound retrotranslocation machinery (7). Determining whether the 
specific PDI-Derlin interaction (or other examples including BiP and Sel1L (26, 
27)) is necessary for Py infection would formally test this hypothesis.  
 
The selection of PQC factors that have physical linkages between the membrane 
and cytosol may also apply. Rescue experiments presented in Chapter 3 reveal 
that B14 must be able to interact with Hsc70-SGTA to promote SV40 infection. 
Future work could investigate the possibility that other ER membrane 
components used by Pys recruit distinct cytosolic factors for viral transport. 
 
The highly abundant cytosolic AAA ATPase p97 provides the critical driving force 
for the mobilization of ERAD substrates into the cytosol (28). Due to several 
interactions with membrane-bound ERAD machinery, p97 is positioned on the 
cytosolic side of the ER membrane (29, 30). Together with cofactors Ufd1 and 
Npl4, p97 uses ATP driven chaperone activity to extract proteins and shuttle 
them to the proteasome. Why does SV40 require SGTA-Hsc70 and not p97-
Ufd1-Npl4 for membrane penetration? One possibility is that unlike canonical 
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ERAD substrates, SV40 is not observed to be ubiquitinated. While p97 can 
engage non-ubiquitinated protein moieties, its cofactors Ufd1 and Npl4 assist in 
ERAD by recognizing polyubiquitin chains, rendering p97 function largely 
ubiquitin-selective (31).  Another molecular pathogen produced by Vibrio 
cholerae, cholera toxin, disguises itself also as noncanonical ERAD substrate 
that is not ubiquitinated and does not require p97 for retrotranslocation (32-35). A 
second explanation stems from the finding that ER membrane components that 
recruit p97, such as Hrd1 and Derlin-1, do not reorganize into SV40-induced foci 
structures. Consequently, foci formation does not increase the local 
concentration of p97 at the site of membrane penetration where it can be co-
opted. 
 
The SV40 induced foci described previously and in Chapter 3 may represent ER 
exit structures for the virus, however direct evidence is still lacking. Once formed, 
these foci containing B14-B12, BAP31 and BiP are mostly static and contain 
deposits of multiple virions. Several lines of evidence from our studies suggest 
that foci formation has a functional role during infection. First, only factors 
involved in ER-to-cytosol transport of SV40 are detected within the foci. 
Secondly, foci formation can be detected within the time frame previously 
observed for cytosol arrival. Thirdly, a B14 mutant lacking most of its lumenal 
domain fails to reorganize into foci and also fails to promote infection in cells 
depleted of endogenous B14. Furthermore, BKPyV appears to localize to 
discrete regions within the ER, suggesting this phenomenon could be general for 
Pys (36). 
 
Virus induced foci are in some ways reminiscent of a number of distinct PQC 
structures that have been observed in yeast and mammalian cells. Some of 
these PQC structures, including aggresomes, IPOD and JUNQ, are proposed to 
be a strategy for the cell to compartmentalize misfolded proteins and aggregates 
in a cytoprotective manner (37-39). These inclusions occur particularly under 
stress conditions where autophagy or proteasome systems are temporarily 
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saturated. Perhaps cellular machinery is attempting to sequester membrane-
bound Pys, which appear as large aggregates. This scenario is not mutually 
exclusive with the putative function of foci as viral ER exit sites. In the case of the 
JUNQ compartment, the compartmentalized misfolded proteins are capable of 
diffusing out of the inclusion for refolding (38). Future studies must thoroughly 
examine and compare the composition of the SV40 foci with other PQC 
structures and investigate any potential interplay with the ubiquitin-proteasome or 
autophagy systems.  
 
SGTA interacts with the B14-B12 complex in a manner dependent on Hsc70. 
Whether Hsc70 is directly important in mobilizing Pys into the cytosol is not 
known. B14 variants which cannot recruit Hsc70 (and consequently SGTA) are 
not able to promote infection of SV40. Minimally, Hsc70 is important for allowing 
SGTA to engage the virus during membrane penetration. Knockdown strategies 
have not been attempted due to the global role of Hsc70 in proteostasis. 
Although technically challenging, one essential goal of future research should be 
to reconstitute these later steps of membrane penetration in vitro. The ATP-
dependence and role of Hsc70 could then be assessed directly. 
 
In summary, the working model of membrane penetration by Pys can be 
elaborated in light of the presented findings. ER arrival of viral particles is met 
with engagement by multiple PDI family members. In the case of mPyV, ERp57 
and PDI work directly to disrupt key disulfide bonds on VP1. The disruption of the 
C19-C114 disulfides, which clamp down the interlocking C-terminal arms, would 
allow ERp29 access to impart conformational changes to unlock the C-terminal 
arms. This ERp29-mediated reaction also results in the exposure of hydrophobic 
VP2, which is otherwise hidden beneath VP1 pentamers. With VP2 exposed the 
intact viral particle can bind to the ER membrane to initiate the penetration. VP2 
embedded in the membrane triggers the reorganization of BAP31, B14 and B12 
in the ER membrane. These factors, along with lumenal BiP, cluster in close 
proximity to viral particles to form foci. Conformational changes induced by BiP 
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binding and release cycles may allow the virus to become exposed to the 
cytosol. The J-domains of complexed B14-B12 recruit cytosolic chaperones, 
including SGTA, to bind and mobilize some particles out of the membrane. The 
foci therefore serve to transiently increase the concentration of cytosolic 
chaperones at the site of ER exit. SGTA-Hsc70 may also promote the 
disassembly of cytosol localized Pys to facilitate viral genome exposure and 




































Figure 4-1. Conceptual Overview of PQC in Py Entry and Proteostasis 
Several similarities are evident between the elimination of misfolded proteins and 
ER membrane penetration by Pys. Both require multiple networks of PQC 
machinery that contribute distinct functions during the process. While the 
destruction of misfolded proteins maintains cellular proteostasis, Py infection can 
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